NIBSC - Complete product list

Product Number	Description
00/410	MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) International Reference Preparation
00/416	Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) International Reference Preparation
00/418	MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) International Standard
00/422	High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) International Reference Preparation
00/440	Influenza Antiserum A/Singapore/1/57 (H2) Influenza
00/442	Influenza anti B/Yamanashi/166/98 Serum Influenza
00/498	Diphtheria Antitoxin Human IgG Working standard single unit sales
00/500	Botulinum Type A-E Antitoxin, Human Serum Non WHO Reference Material
00/542	Influenza anti- A/Chick/Scotland/59 (H5N1) Serum Influenza
00/546	Influenza Antigen B/Johannesburg/5/99 Influenza
00/548	Influenza Antigen A/Singapore/1/57 (H2N2) Influenza
00/552	Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3) Influenza
00/556	Influenza anti-B/Johannesburg/5/99/ Serum Influenza
00/572	Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard) International Standard
00/574	Interferon Beta SER17 Mutein (Human, rDNA derived) Non WHO Reference Material
00/576	Interferon Beta (Human, Fibroblast-derived, Glycosylated) Non WHO Reference Material
007SP	Human Anti-Pneumococcal capsule Reference Serum (1st International Standard) International Standard
01/412	Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody Non WHO Reference Material
01/420	Interleukin-17 (Human rDNA derived)(WHO Reference Reagent) International Reference Reagent
01/450	Influenza anti B/Guangdong/120/2000 Serum Influenza
01/452	Influenza anti A/Panama/2007/99 (H3N2) HA serum Influenza
01/506	Botulinum type F antitoxin, equine Non WHO Reference Material
01/508	Botulinum type C antitoxin, equine Non WHO Reference Material
01/510	Botulinum Antitoxin Equine Type D Non WHO Reference Material
01/512	Botulinum type G antitoxin, equine Non WHO Reference Material
01/514	Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody Non WHO Reference Material
01/538	Anti-Meningococcal Serosubtype P1.16 mAb Non WHO Reference Material
01/546	Influenza Antigen B/Guangdong/120/2000 Influenza
01/600	Anti-Toxoplasma IgG, Human(International Standard) International Standard
01/602	Anti-Parvovirus B19, plasma, human(2nd International Standard) International Standard
01/612	Influenza Virus infectious B/Hawaii/10/01 Influenza
01/614	Influenza Antigen A/New Caledonia/20/99 Influenza
02/102	Influenza anti A/Panama/2007/99 Serum Influenza
02/144	Anti-Meningococcal Serosubtype P1.15 mAb Non WHO Reference Material
02/148	Anti-Meningococcal Serosubtype P1.4 mAb Non WHO Reference Material
02/178	Anti-Meningococcal Serosubtype P1.2 mAb Non WHO Reference Material
02/180	Anti-Meningococcal Serotype P2.2a mAb Non WHO Reference Material
02/182	Anti-Japanese Encephalitis Virus Plasma, Human Non WHO Reference Material
02/184	Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human Non WHO Reference Material
02/210	HIV (antibody), 1st International Reference Panel International Reference Preparation
02/226	IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent) International Reference Reagent
02/228	IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent) International Reference Reagent
02/230	Biotinylated Brad-5 (Bio-Brad-5) Working Standard
02/232	Tetanus Toxoid (Non-Adsorbed) Non WHO Reference Material
02/294	Influenza Antiserum A/chick/Italy/1347/99 (H7N1) Influenza
02/308	Anti-Meningococcal Serotype P3.4 mAb Non WHO Reference Material
02/310	Anti-Meningococcal Serotype P3.15 mAb Non WHO Reference Material
02/318	Botulinum Antitoxin Equine Type E Non WHO Reference Material
02/320	Anti-Meningococcal Serosubtype P1.3 mAb Non WHO Reference Material
02/336	Influenza Antigen A/New Caledonia/20/99 Influenza
02/338	Influenza anti A/Panama/2007/99 Serum Influenza
02/342	Protein C Plasma, Human(2nd International Standard) International Standard
03/104	HTLV-1 (antibody) Monitor Sample European Certification
03/110	Influenza anti B/Shangdong/9/97 Serum Influenza
03/114	Anti-Meningococcal Serosubtype P1.1 mAb Non WHO Reference Material
03/124	Thrombopoietin ( Human rDNA derived) Non WHO Reference Material
03/142	Anti-Meningococcal Serosubtype P1.14 mAb Non WHO Reference Material
03/148	Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent) International Reference Reagent
03/150	Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent) International Reference Reagent
03/152	Anti-HPA-1a (International Standard) International Standard
03/164	Anti-B minimum potency reference preparation(International Standard) International Standard
03/178	Vitamin B12, Serum Folate and holoTC (International standard) International Standard
03/182	Anti-Meningococcal Serotype P3.21 mAb Non WHO Reference Material
03/188	Anti-A minimum potency reference preparation(International Standard) International Standard
03/190	Anti-HPA-3a(minimum potency)(WHO Reference Reagent) International Reference Reagent
03/192	Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard) International Standard
03/200	Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent) International Reference Reagent
03/210	Anti-Meningiococcal Serosubtype P1.6 mAb Non WHO Reference Material
03/212	Influenza anti A/Wyoming/03/03 Serum Influenza
03/220	Influenza Antigen A/Wyoming/03/03 Influenza
03/224	Anti-Meningococcal Serosubtype P1.10 mAb Non WHO Reference Material
03/226	Anti-Meningococcal Serosubtype P1.5 mAb Non WHO Reference Material
03/228	Protein S, Plasma, Human(2nd International Standard) International Standard
03/236	Anti-Meningococcal Serosubtype P1.13 mAb Non WHO Reference Material
03/242	Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum Influenza
03/244	Influenza Antiserum A/chick/Germany/N/49 Influenza
03/258	Influenza Antigen A/New Caledonia/20/99 (IVR-116) Influenza
03/262	Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel) International Reference Preparation
04/122	Anti-Meningococcal Serosubtype P1.12 mAb Non WHO Reference Material
04/160	Influenza Virus infectious NYMC X-147 Influenza
04/166	TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent) International Reference Reagent
04/170	Influenza Virus infectious A/Wellington/1/2004 Influenza
04/172	Influenza Virus infectious IVR-139 Influenza
04/176	Plasmodium falciparum DNA for NAT Assays(1st International Standard) International Standard
04/198	Anti-Meningococcal Serotype P3.1 mAb Non WHO Reference Material
04/202	Influenza Antigen B/ Jiangsu/10/2003 Influenza
04/224	Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 International Standard
04/228	Influenza anti B/ Neuraminidase Serum Influenza
04/242	Influenza anti B/Jiangsu/10/2003 HA Serum Influenza
04/246	Anti-Meningococcal Serogroup W-135 mAb Non WHO Reference Material
04/248	Anti-Meningococcal Serosubtype P1.19 mAb Non WHO Reference Material
04/252	Protein C Concentrate, Human(1st International Standard) International Standard
04/260	Influenza anti A/New Caledonia/20/99 HA Serum Influenza
04/262	Influenza anti A/New York/55/2004 HA Serum Influenza
04/264	Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157) Influenza
05/102	Influenza Virus infectious NYMC BX-7 Influenza
05/106	Anti-HPA-1a minimum potency reagent (2nd WHO Reference reagent) International Reference Reagent
05/112	Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard). International Standard
05/130	Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005) International Standard
05/134	Anti-human papillomavirus type 16 serum (1st International Standard) International Standard
05/162	Alpha-1-Antitrypsin, plasma derived(1st International standard) International Standard
05/190	Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody Non WHO Reference Material
05/192	Anti Meningococcal Serotype P2.2b Monoclonal Antibody Non WHO Reference Material
05/234	Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142) Influenza
05/236	Influenza anti A/Wisconsin/67/2005 Serum Influenza
05/252	Influenza anti B Neuraminidase Serum Influenza
06/108	Influenza Virus infectious IVR-116 Influenza
06/124	Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard) International Standard
06/128	Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard) International Standard
06/140	Pertussis Antiserum(human)1st IS-WHO international Standard. International Standard
06/142	Pertussis Antiserum (Human) 1st WHO Reference Reagent International Reference Reagent
06/164	Influenza Virus infectious 1 VR-142 Influenza
06/166	Antithrombin Concentrate, Human (3rd International Standard) International Standard
06/170	Influenza Antigen A/New Caledonia/20/99 Influenza
06/192	Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466) Influenza
06/202	Human Papillomavirus (HPV) Type 16 DNA (1st International Standard) International Standard
06/206	Human Papillomavirus (HPV) Type 18 DNA (1st International Standard) International Standard
06/242	Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR) Influenza
0688	SARS CoV-1 spike S1 protein NIBSC Repository - Research Use Only
07/102	Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145) Influenza
07/104	Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum Influenza
07/112	Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 Influenza
07/144	Influenza Virus infectious IVR-145, Influenza
07/146	Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep) Influenza
07/148	Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum Influenza
07/150	Human Plasma Anti-Influenza H5N1 (1st International Standard) International Standard
07/164	Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard) International Standard
07/184	Influenza anti B/Malaysia/2506/2004-HA Serum Influenza
07/202	Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent) International Reference Reagent
07/216	Diphtheria Toxoid (Adsorbed) (4th International Standard) International Standard
07/222	RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent) International Reference Reagent
07/228	Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” International Standard
07/270	BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent) International Reference Reagent
07/272	BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent) International Reference Reagent
07/274	BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) International Reference Reagent
07/278	Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475) Influenza
07/286	Monitor sample for HBsAg 0.05IU/ml European Certification
07/288	Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml European Certification
07/290	Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 Influenza
07/306	Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent) International Reference Reagent
07/316	Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.) International Standard
07/318	Meningococcal Group C Polysaccharide Non WHO Reference Material
07/328	Unfractionated Heparin (6th I.S.) International Standard
07/336	Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60 Influenza
07/338	Influenza antiserum A/Anhui/1/05 (H5) Influenza
07/348	Influenza Virus infectious NYMC X-171B Influenza
07/350	Blood Coagulation Factor VIII Concentrate (8th I.S.) International Standard
07/358	Influenza Virus infectious NIB-50 Influenza
07/362	Influenza Virus infectious IVR-149 Influenza
08/100	Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1) Influenza
08/108	Influenza Virus Infectious NIBRG-91 (H9N2) Influenza
08/126	Influenza Anti N1 Neuraminidase Serum SH485 Influenza
08/138	Influenza Virus Infectious B/Florida/4/2006 Influenza
08/140	Influenza Antigen B/Florida/4/2006 Influenza
08/142	Influenza antiserum A/Anhui/1/05 (H5) Influenza
08/154	Influenza Virus Infectious NIBRG-12 (H5N1) Influenza
08/156	Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1) Influenza
08/158	Fragile X Syndrome gDNA (1st International Genetic Reference Panel) International Standard
08/160	Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel) International Standard
08/184	Influenza Antigen B/Malaysia/2506/2004 Influenza
08/202	Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1) Influenza
08/204	Thyroid Stimulating Antibody (2nd I.S.) International Standard
08/208	Influenza Antigen A/HongKong/1073/99 (H9N2) Influenza
08/210	Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86) Influenza
08/216	Influenza Antigen A/Cambodia/RO405050/2007 (H5N1) Influenza
08/218	Tetanus Toxoid Adsorbed (4th International Standard) International Standard
08/228	Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91 Influenza
08/230	Streptodornase (2nd International Standard) International Standard
08/246	Influenza anti A/Brisbane/10/2007- like HA serum Influenza
08/248	Influenza Virus Infectious NIBRG-107 VE2 30480 Influenza
08/250	Influenza Virus Infectious NIBRG-63 VE2 30500 (H7N1) Influenza
08/252	Influenza Virus Infectious NIBRG-109 VE2 30490 Influenza
08/256	C1- Inhibitor, Concentrate (1st International Standard) International Standard
08/258	Antithrombin, Plasma (3rd International Standard) International Standard
08/262	C1 Inhibitor (Plasma)(1st International Standard) International Standard
08/266	Sex Hormone Binding Globulin.(2nd International Standard) International Standard
08/268	Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107 Influenza
08/278	Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C)) Influenza
08/298	Influenza Virus Infectious B/Brisbane/33/2008 30720 E5 Influenza
08/300	Influenza Virus Infectious IVR-148 Influenza
08/304	Influenza virus infectious NYMC X-175C Influenza
08/322	Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing Clinical Virology Network
08/356	Influenza antiserum A/Japan/305/57 (H2) Influenza
08/362	Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109 Influenza
09/100	Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503) Influenza
09/110	Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard) International Standard
09/130	Influenza Virus Infectious NIBRG-122 Influenza
09/136	Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard) International Standard
09/138	Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.) International Standard
09/140	Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel) International Standard
09/148	Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505) Influenza
09/162	Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard) International Standard
09/170	Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody Non WHO Reference Material
09/172	Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010) International Standard
09/174	Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived) Influenza
09/182	VWF Factor Concentrate (2nd International Standard) International Standard
09/184	Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14 Influenza
09/186	Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard) International Standard
09/188	Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard) International Standard
09/196	Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived) Influenza
09/222	Human anti-Haemophilus influenzae b reference serum European Certification
09/234	Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard) International Standard
09/236	Influenza Virus Infectious IVR-153 Influenza
09/242	Fibrinogen Concentrate (B)(2nd International Standard) International Standard
09/260	Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard) International Standard
09/264	Fibrinogen Plasma (D)(3rd International Standard) International Standard
09/266	GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived Non WHO Reference Material
09/268	Influenza Virus Infectious NIBRG-121xp Influenza
09/272	Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1) Non WHO Reference Material
09/274	Influenza Virus Infectious NYMC X-185 Influenza
09/280	Influenza Virus Infectious NIB-64 Influenza
09/284	Anti-Human Neutrophil Antibody 1a WHO Reference Reagent International Reference Reagent
09/296	Pro-Insulin, human (1st International Standard) International Standard
09/304	Influenza Virus Infectious IVR-155 Influenza
09/308	Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay Working standard single unit sales
09/310	Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183) Influenza
10/104	Reteplase Reference Material Non WHO Reference Material
10/120	Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum Influenza
10/128	Diphtheria Polyclonal Antibody Non WHO Reference Material
10/130	Diphtheria Monoclonal Antibody Non WHO Reference Material
10/132	Tetanus Polyclonal Antibody Non WHO Reference Material
10/134	Tetanus Monoclonal Antibody Non WHO Reference Material
10/140	Anti-human papillomavirus[HPV] 18 serum (1st International Standard) International Standard
10/142	Anti-human leukocyte antigen antibodies (negative plasma) International Reference Reagent
10/164	Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain]. International Reference Reagent
10/168	Oral Poliovaccine Sabin Type 3 reference International Reference Reagent
10/176	Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent International Reference Reagent
10/178	Endotoxin (3rd International Standard) International Standard
10/198	Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent) International Reference Reagent
10/202	Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard) International Standard
10/214	Influenza Anti N2 Neuraminidase Serum SH395 & SH396 Influenza
10/218	Influenza Anti A/California/7/2009 (N1) NA Serum Influenza
10/226	Influenza Virus Infectious IVR-158 Influenza
10/232	Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent) International Reference Reagent
10/234	Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent) International Reference Reagent
10/236	Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent) International Reference Reagent
10/238	Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent) International Reference Reagent
10/242	Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard) International Standard
10/252	Factor VII Concentrate (2nd International Standard) International Standard
10/258	Influenza Antigen A/California/7/2009-like(NIB-74) Influenza
10/262	Diphtheria Antitoxin Human IgG(1st International Standard) International Standard
10/272	BCG vaccine of Moreau-RJ sub-strain (1st WHO Reference Reagent) International Reference Reagent
100976	pCAGGS-SARS-CoV-2-Spike NIBSC Repository - Research Use Only
100978	VeroE6/TMPRSS2 NIBSC Repository - Research Use Only
100980	SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020 NIBSC Repository - Research Use Only
100985	pCAGGS_SARS-CoV-2_Spike D614G NIBSC Repository - Research Use Only
100986	pCAGGS-SARS-CoV-2-Spike Bristol Deletion NIBSC Repository - Research Use Only
100987	Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 NIBSC Repository - Research Use Only
100988	Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 NIBSC Repository - Research Use Only
100989	pCRII-SARS-CoV-2 (5'UTR-NSP2) NIBSC Repository - Research Use Only
100991	pCRII-SARS-CoV-2 (NSP4-NSP8) NIBSC Repository - Research Use Only
100992	pCRII-SARS-CoV-2 (NSP4-NSP8) NIBSC Repository - Research Use Only
100994	pCRII-SARS-CoV-2 (NSP15-NSP16) NIBSC Repository - Research Use Only
100996	pCRII-SARS-CoV-2 (ORF3a-ORF6) NIBSC Repository - Research Use Only
100998	SARS-CoV-2 infectious virus (CVR-GLA 1) NIBSC Repository - Research Use Only
100999	SARS-CoV-2 infectious virus(CVR-GLA 2) NIBSC Repository - Research Use Only
101000	SARS-CoV-2 infectious virus(CVR-GLA 3) NIBSC Repository - Research Use Only
101001	VeroE6-ACE2 NIBSC Repository - Research Use Only
101003	VeroE6-ACE2-TMPRSS2 NIBSC Repository - Research Use Only
101004	A549-ACE2-TMPRSS2 NIBSC Repository - Research Use Only
101005	A549-ACE2 Clone8 NIBSC Repository - Research Use Only
101006	A549-ACE-2 Clone 8-TMPRSS2 NIBSC Repository - Research Use Only
101007	SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020 NIBSC Repository - Research Use Only
101008	HEK293T-ACE2-TMPRSS2 NIBSC Repository - Research Use Only
101009	Anti-SARS-CoV-2 Nucleocaspid protein (CR3009) NIBSC Repository - Research Use Only
101010	Anti-SARS-CoV-2 Nucleocapsid protein (CR3018) NIBSC Repository - Research Use Only
101019	VOC-202012/01 (B.1.1.7 lineage) lot 26012021 NIBSC Repository - Research Use Only
101022	SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4 NIBSC Repository - Research Use Only
101023	pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021 NIBSC Repository - Research Use Only
101024	pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021 NIBSC Repository - Research Use Only
101025	4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2 NIBSC Repository - Research Use Only
101027	Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021 NIBSC Repository - Research Use Only
101029	SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021 NIBSC Repository - Research Use Only
101030	SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage) NIBSC Repository - Research Use Only
101031	SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage + E484K) NIBSC Repository - Research Use Only
101032	SARS-CoV-2 Kappa (B.1.617.1 lineage NIBSC Repository - Research Use Only
101033	SARS-CoV-2 Delta (AY.1 sub-lineage) NIBSC Repository - Research Use Only
101034	SARS-CoV-2 Mu (B.1.621 lineage) NIBSC Repository - Research Use Only
101035	Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage) NIBSC Repository - Research Use Only
101036	Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage NIBSC Repository - Research Use Only
101037	Inactivated (acetic acid + heat) SARS-CoV-2 Gamma (P.1 lineage) NIBSC Repository - Research Use Only
101038	0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage) NIBSC Repository - Research Use Only
101039	0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage) NIBSC Repository - Research Use Only
101042	SARS-CoV-2 Nucleocapsid protein (His tagged) NIBSC Repository - Research Use Only
101043	SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged) NIBSC Repository - Research Use Only
101044	SARS-CoV-2 Omicron (lineage B.1.1.529) NIBSC Repository - Research Use Only
101047	Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage) NIBSC Repository - Research Use Only
101054	SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022 NIBSC Repository - Research Use Only
101055	SARS-CoV-2 Omicron (BA.2) NIBSC Repository - Research Use Only
101062	HEK293T-ACE2-30F-PLP2 NIBSC Repository - Research Use Only
101063	SARS-CoV-2 Omicron - BA.1 lineage NIBSC Repository - Research Use Only
101066	SARS-CoV-2 Omicron - BA.2.75.3 lineage NIBSC Repository - Research Use Only
101067	SARS-CoV-2 Omicron - BA.4.6 lineage NIBSC Repository - Research Use Only
101068	SARS-CoV-2 Omicron - BA.2.3.20 lineage NIBSC Repository - Research Use Only
101069	SARS-CoV-2 Omicron - BA.5.1.17 lineage NIBSC Repository - Research Use Only
101070	SARS-CoV-2 Omicron - BF.7.5 lineage NIBSC Repository - Research Use Only
101071	SARS-CoV-2 Omicron - BF.1 lineage NIBSC Repository - Research Use Only
101072	SARS-CoV-2 Omicron - BE.1 lineage NIBSC Repository - Research Use Only
101073	SARS-CoV-2 Omicron - Recombinant XAH lineage NIBSC Repository - Research Use Only
101074	SARS-CoV-2 Omicron - Recombanant XAZ lineage NIBSC Repository - Research Use Only
101075	SARS-CoV-2 Omicron - BA.4 lineage NIBSC Repository - Research Use Only
101076	SARS-CoV-2 Omicron - BA.5.1 lineage NIBSC Repository - Research Use Only
101077	SARS-CoV-2 Omicron - Recombinant XAK lineage NIBSC Repository - Research Use Only
101079	Nucleic acid extracts from inactivated (acetic acid + heat) SARS-CoV-2 Gamma (P.1 lineage) NIBSC Repository - Research Use Only
101084	Nucleic acid extracts from inactivated (acetic acid + heat) SARS-CoV-2 Beta (B.1.351 lineage) NIBSC Repository - Research Use Only
101085	Nucleic acid extracts from inactivated (acetic acid + heat) SARS-CoV-2 Delta (B.1.617.2 lineage) NIBSC Repository - Research Use Only
101093	SARS-CoV-2 Omicron - BA.4.6 lineage NIBSC Repository - Research Use Only
101095	SARS-CoV-2 Gamma - P.1 lineage NIBSC Repository - Research Use Only
101096	SARS-CoV-2 Alpha - B.1.1.7 lineage NIBSC Repository - Research Use Only
101097	SARS-CoV-2 Beta - B.1.351 lineage NIBSC Repository - Research Use Only
101098	SARS-CoV-2 Epsilon - B.1.427 lineage NIBSC Repository - Research Use Only
101099	SARS-CoV-2 Epsilon - B.1.429 lineage NIBSC Repository - Research Use Only
101100	SARS-CoV-2 Eta - B.1.525 lineage NIBSC Repository - Research Use Only
101101	SARS-CoV-2 Iota - B.1.526 lineage NIBSC Repository - Research Use Only
101102	SARS-CoV-2 Delta - B.1.617.2 lineage NIBSC Repository - Research Use Only
101103	SARS-CoV-2 Mu - B.1.621 lineage NIBSC Repository - Research Use Only
101104	SARS-CoV-2 Omicron - BA.1.1 lineage NIBSC Repository - Research Use Only
101105	SARS-CoV-2 Omicron - BA.2 lineage NIBSC Repository - Research Use Only
101106	SARS-CoV-2 Omicron - BA.2.9.3 lineage NIBSC Repository - Research Use Only
101107	SARS-CoV-2 Omicron - Recombinant XZ lineage NIBSC Repository - Research Use Only
101108	SARS-CoV-2 Omicron - Recombinant XBB lineage NIBSC Repository - Research Use Only
101109	SARS-CoV-2 Deltacron - Recombinant XD lineage NIBSC Repository - Research Use Only
101110	SARS-CoV-2 Omicron - Recombinant XN lineage NIBSC Repository - Research Use Only
101111	SARS-CoV-2 Omicron - BQ.1 lineage NIBSC Repository - Research Use Only
101112	SARS-CoV-2 Omicron - BQ.1.14 lineage NIBSC Repository - Research Use Only
101116-A	Anti-SARS-CoV-2 RBD Wuhan-variant specific monoclonal antibody, Clone 486 NIBSC Repository - Research Use Only
101116-B	Anti-SARS-CoV-2 RBD Wuhan-variant specific monoclonal antibody, Clone 486 NIBSC Repository - Research Use Only
101117-A	Anti-SARS-CoV-2 RBD Delta-variant specific monoclonal antibody, clone 215 NIBSC Repository - Research Use Only
101117-B	Anti-SARS-CoV-2 RBD Delta-variant specific monoclonal antibody, Clone 215 NIBSC Repository - Research Use Only
101118-A	Anti-SARS-CoV-2 RBD Omicron-variant specific monoclonal antibody, clone 304 NIBSC Repository - Research Use Only
101118-B	Anti-SARS-CoV-2 RBD Omicron-variant specific monoclonal antibody, clone 304 NIBSC Repository - Research Use Only
101119-A	Anti-SARS-CoV-2 RBD Cross reactive monoclonal antibody, clone 175 NIBSC Repository - Research Use Only
101119-B	Anti-SARS-CoV-2 RBD Cross reactive monoclonal antibody, clone 175 NIBSC Repository - Research Use Only
1050	IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050) Non WHO Reference Material
11/108	Influenza Virus infectious NYMC X-187 Influenza
11/126	Factors II and X Concentrate (4th International standard) International Standard
11/134	Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived) Influenza
11/170	Erythropoietin, recombinant, for Bioassay (3rd International Standard) International Standard
11/176	(3rd International Standard) Low Molecular Weight Heparin International Standard
11/184	High Molecular Weight Urokinase(2nd International Standard) International Standard
11/206	Influenza anti-A/Perth/16/2009 HA Serum Influenza
11/210	Anti-human CD4 FITC conjugated 0.5ml Non WHO Reference Material
11/212	Biosynthetic Human Insulin (2nd WHO international Standard) International Standard
11/214	Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent) International Reference Reagent
11/216	Chagas Antibody Reference Panel ( 1st International Standard) International Standard
11/222	Influenza Virus Infectious NIB-79 Influenza
11/232	Influenza Virus Infectious B/Texas/6/2011 Influenza
11/234	Immunoglobulin E(IgE) human serum (3rd International Standard) International Standard
11/242	Viral Multiplex Reference Non WHO Reference Material
11/244	Influenza Virus Infectious NYMC BX-49 Influenza
12/100	Influenza Virus Infectious NYMC X-217 Influenza
12/104	International Standard for IPV 12/104 (3rd International Standard) International Standard
12/106	Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39) Influenza
12/110	Influenza Antigen B/Wisconsin/1/2010 (cell derived) Influenza
12/112	Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187) Influenza
12/114	Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165) Influenza
12/116	Influenza anti-A/Victoria/361/2011-like HA serum Influenza
12/118	Influenza anti-B/Wisconsin/1/2010-like HA serum Influenza
12/122	Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1) Influenza
12/154	Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard) International Standard
12/188	Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard) International Standard
12/198	Influenza virus infectious B/Wisconsin/1/2010 34490 E5 Influenza
12/202	Influenza virus infectious NYMC BX-39 Influenza
12/204	Influenza Virus infectious IVR-165 Influenza
12/208	Parvovirus B19 (3rd International Standard) International Standard
12/224	HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation) International Reference Preparation
12/226	HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard) International Standard
12/244	Vi polysaccharide of C freundii WHO 1st International Standard International Standard
12/250	Influenza anti A/Mallard/England 727/2006 (H2) HA Serum Influenza
12/252	ADAMTS 13 Plasma (1st International Standard) International Standard
12/278	2nd Pneumococcal QC Serum Panel International Standard
12/282	Diphtheria Toxin 1Lf/ml Non WHO Reference Material
12/284	Anti-meningococcal serogroup Y monoclonal antibody Non WHO Reference Material
12/290	Influenza Virus Infectious B/Brisbane/36/2012 Influenza
12/294	Influenza Virus Infectious NYMC BX-51C Influenza
12/300	Negative Control IVIG (for use with IVIG and Anti-D) Non WHO Reference Material
12/306	Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard) International Standard
13/100	Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard) International Standard
13/106	Influenza Antigen B/Massachusetts/02/2012 Influenza
13/108	Anti-Meningococcal serogroup B monoclonal antibody Non WHO Reference Material
13/112	Influenza Antigen A/Texas/50/2012 (NYMC X-223) Influenza
13/116	Influenza Antigen A/Texas/50/2012 (NYMC X-223A) Influenza
13/122	Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel) International Standard
13/126	Influenza anti-B/Brisbane/60/2008-like HA serum Influenza
13/128	Influenza Virus Infectious NIBRG-269 Influenza
13/132	Antibodies, Human, to Toxoplasma gondii (4th International Standard). International Standard
13/134	Influenza Antigen B/Massachusetts/02/2012 (Egg derived) Influenza
13/146	C-Peptide, Human (1st International Standard). International Standard
13/148	IVIG + anti-D for use with negative control IVIG Non WHO Reference Material
13/152	Influenza Antigen B/Massachusetts/02/2012 (Cell Derived) Influenza
13/162	Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived) Influenza
13/164	Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A) Influenza
13/166	Influenza anti-A/Anhui/1/2013 (N9) NA Serum Influenza
13/168	Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques Clinical Virology Network
13/172	Lupus Anticoagulant (1st International Reference Panel) International Reference Preparation
13/176	Influenza Virus Infectious NIBRG-88 Influenza
13/178	Influenza Anti-A/Texas/50/2012-like HA Serum Influenza
13/182	Influenza Anti-B/Massachusetts/02/2012-like HA Serum Influenza
13/200	Influenza Virus Infectious NIB-74 Influenza
13/202	Influenza Virus Infectious NIB-74xp Influenza
13/204	TNF Rec II- FC Fusion protein (1st International Standard) International Standard
13/206	Plasmin (4th International Standard) International Standard
13/212	Diphtheria Toxoid for use in Flocculation Test (3rd International Standard) International Standard
13/214	HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel) International Reference Preparation
13/216	Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal Non WHO Reference Material
13/218	Polio Anti Sabin type 1 (inactivated) Serum Non WHO Reference Material
13/220	Polio Anti Sabin type 2 (inactivated) serum Non WHO Reference Material
13/222	Polio Anti Sabin type 3 (inactivated) serum Non WHO Reference Material
13/224	Influenza virus Infectious NIB-85. 36210 E5 Influenza
13/228	Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4 Influenza
13/234	Influenza antigen B/Brisbane/60/08 Influenza
13/238	Anti-EV71 serum LOW (WHO Reference Reagent) International Reference Reagent
13/240	Tetanus Immunoglobulin, Human (2nd WHO International Standard) International Standard
13/242	FEIBA Concentrate 2nd NIBSC Working Reference Standard Working Standard
13/246	Meningococcal serogroup A polysaccharide (1st WHO International Standard). International Standard
13/248	Influenza virus infectious NIBRG-267 (H7N9) Influenza
13/250	Influenza Virus Infectious NIBRG-268 (H7N9) Influenza
13/252	Influenza virus infectious NYMC X-223A Influenza
13/256	Influenza virus infectious. NYMC x-233 Influenza
13/258	Influenza virus infectious NYMC X-233A Influenza
13/262	Meningococcal serogroup A polysaccharide Non WHO Reference Material
13/264	Influenza Virus Infectious NYMC X-223 Influenza
14/100	Human Papillomavirus (HPV) 11 DNA (1st International Standard) International Standard
14/104	Human Papillomavirus (HPV) Type 45 DNA (1st International Standard) International Standard
14/106	Influenza virus infectious. NYMC BX-51B Influenza
14/114	JC Virus (JCV) DNA (1st International Standard) International Standard
14/116	Influenza virus infectious NYMC X-179A Influenza
14/118	Influenza virus infectious B/Massachusetts/2/2012 Influenza
14/140	1st International Standard for Anti EV71 Serum Human International Standard
14/144	Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) Influenza
14/146	Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived) Influenza
14/148	Human Blood Factor IX Concentrate (5th International Standard). International Standard
14/156	Meningococcal group X polysaccharide (1st WHO International Standard) International Standard
14/160	High titre anti-A in IVIG working reference reagent Working Standard
14/174	Botulinum Type A Antitoxin, Equine Non WHO Reference Material
14/198	HBV,HCV,HIV Multiplex Clinical Virology Network
14/200	Influenza Antigen A/Puerto Rico/8/34 (HINI) Influenza
14/206	Influenza virus infectious NYMC X-247 Influenza
14/210	Biological activities of Rituximab WHO 1st International Standard International Standard
14/212	BK Virus (BKV)(1st International Standard) International Standard
14/224	Influenza virus infectious. A/Switzerland/9715293/2013 Influenza
14/226	Influenza Virus Infectious A/South Australia/55/2014 Influenza
14/228	Influenza Virus Infectious A/Stockholm/6/2014 Influenza
14/230	Influenza Virus Infectious. A/Norway/466/2014 Influenza
14/232	Influenza Virus Infectious IVR-175 Influenza
14/238	Recombinant Tissue factor Working standard single unit sales
14/254	Influenza Antigen A/Switzerland/9715293/2013 (NIB88) Influenza
14/256	Human Papillomavirus (HPV) Type 6 DNA (1st International Standard) International Standard
14/258	Human Papillomavirus (HPV) Type 31 DNA (1st International Standard) International Standard
14/260	Human Papillomavirus (HPV) Type 33 DNA (1st International Standard) International Standard
14/262	Human Papillomavirus (HPV) Type 52 DNA (1st International Standard) International Standard
14/264	Human Papillomavirus (HPV) Type 58 DNA (1st International Standard) International Standard
14/274	Influenza Antigen B/Brisbane/9/2014 (Egg Derived) Influenza
14/300	High titre anti-A and anti-B in serum (WHO Reference Reagent). International Reference Reagent
14/306	Influenza Virus Infectious NYMC X-243 40180 E13 Influenza
14/308	Influenza Virus Infectious IVR-178 40200 E7 Influenza
14/314	Influenza Virus Infectious NIB-88 Influenza
14/316	Factor IX activated (FIXa) 2nd WHO International Standard International Standard
14/318	Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625) Influenza
14/322	Influenza Virus Infectious NIB-91 Influenza
15/100	Influenza Antigen B/Utah/9/2014 (Cell Derived) Influenza
15/102	Activated Blood Coagulation Factor X (FXa), Human International Reference Reagent
15/104	Influenza Antigen A/South Australia/55/2014 Cell derived Influenza
15/106	Ancrod International Standard
15/126	Bordetella pertussis toxin (20µg). (2nd International Standard) International Standard
15/130	Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT) Clinical Virology Network
15/134	Influenza Anti-A Switzerland/9715293/2013-Like HA serum Influenza
15/136	EBOV RNA NP-VP35-GP in-run control International Reference Reagent
15/138	EBOV RNA VP40-L in-run control International Reference Reagent
15/140	Batroxobin International Reference Reagent
15/148	Influenza Virus Infectious NIB-92 Influenza
15/154	Influenza Virus Infectious NIB-93 Influenza
15/158	Influenza Virus Infectious NYMC X-263 Influenza
15/160	Influenza Virus Infectious NIBRG-306 Influenza
15/174	Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent International Reference Reagent
15/180	Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard) International Standard
15/182	7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate Working Standard
15/184	Influenza Virus Infectious NYMC X-263B Influenza
15/188	Influenza Virus Infectious NYMC X-263A Influenza
15/194	Influenza Virus Infectious NYMC X-257A Influenza
15/196	Influenza Virus Infectious NYMC X-261 Influenza
15/212	Influenza Virus Infectious NYMC BX-53C Influenza
15/220	Anti-EBOV plasma, human (WHO Reference Reagent) International Reference Reagent
15/222	EBOV RNA NP-VP35-GP (WHO Reference Reagent) International Reference Reagent
15/224	EBOV RNA VP40-L (WHO Reference Reagent) International Reference Reagent
15/234	Influenza Virus Infectious B/Texas/2/2013 41340 E7 Influenza
15/238	Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen) Influenza
15/240	Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel) International Standard
15/242	Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel) International Standard
15/248	Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645) Influenza
15/250	Influenza Virus Infectious NYMC BX-31 Influenza
15/262	1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool International Standard
15/266	HHV-6 Virus 1st WHO International Standard International Standard
15/270	1st WHO International Reference Reagent CD4 T-cells (human) International Reference Reagent
15/272	ICS Positive Control-Lymphocytes Non WHO Reference Material
15/276	Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard) International Standard
15/294	Influenza virus infectious NYMC BX-59B Influenza
15/296	Sabin monovalent Polio vaccine type 2 (1st International Standard) International Standard
15/298	Influenza Virus Infectious B/Brisbane/46/2015 Influenza
15/300	Influenza Virus Infectious NYMC BX-35 41950 E11 Influenza
15/304	Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard International Standard
16/106	Influenza antigen A/California/7/09 (H1N1) (NYMC-X181) Influenza
16/108	Influenza Virus Infectious A/PR/8/34 Influenza
16/110	Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT) Non WHO Reference Material
16/114	Influenza anti - A/California/7/09 HA serum Influenza
16/118	Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived) Influenza
16/120	WHO 1st International Reference Panel for Genomic JAK2 V617F International Standard
16/126	Native Vi polysaccharide (S. Typhi) (1st International Standard) International Standard
16/138	Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard International Standard
16/152	Meningococcal Serogroup W Polysaccharide International Standard
16/164	Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard) International Standard
16/170	Infliximab (1st International Standard) International Standard
16/182	Influenza Anti-A/Hong Kong/4801/2014-like HA Serum Influenza
16/190	Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent) International Reference Reagent
16/192	Influenza Anti - B/Brisbane/60/2008-HA serum Influenza
16/194	HIV-1 RNA (4th International Standard) International Standard
16/196	Sabin monovalent Polio vaccine type 1(1st International Standard) International Standard
16/200	Influenza Virus Infectious NIB-58 Influenza
16/202	OPV reference mOPV 3 International Standard
16/204	7th WHO International Standard for Rabies Vaccine International Standard
16/206	Meningococcal serogroup Y Polysaccharide International Standard
16/208	Influenza Virus Infectious NIB-97 42090 E7 Influenza
16/210	HIV-1 P24 Antigen (1st international reference panel) International Standard
16/236	HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent) International Reference Reagent
16/238	Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9) Influenza
16/242	Influenza Virus Infectious NIB-98 42110 E7 Influenza
16/250	1st International Reference Panel for genomic KRAS codons 12 and 13 mutations International Standard
16/268	Influenza Virus Infectious X-273 Influenza
16/270	Influenza Virus Infectious IVR-180 42400 E3/D7/E1 Influenza
16/274	Influenza Virus Infectious X-275A 42010 E13 Influenza
16/278	Anti-D Immunglobulin control preparation Working standard single unit sales
16/282	Influenza Virus Infectious X-285 42430 ExE1 Influenza
16/284	Antiserum to Respiratory Syncytial Virus (WHO 1st International Standard) International Standard
16/286	Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B) Influenza
16/288	Influenza Virus Infectious X-283A 42420 ExE1 Influenza
16/290	Influenza Virus Infectious X-285A 42440 ExE1 Influenza
16/292	Influenza Antigen A/Singapore/GP1908/2015 (IVR-180) Influenza
16/296	Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard) International Standard
16/302	Tetanus Toxoid for use in Flocculation Test (3rd International Standard) International Standard
16/320	Zika Antibody Working reagent Working standard single unit sales
16/324	Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard). International Standard
16/332	Anti-D Immunoglobulin (Replacement IS) International Standard
16/344	WHO Anti-EBOV Convalescent Plasma (International Reference Panel) International Reference Preparation
16/352	Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard) International Standard
16/358	Streptokinase (4th WHO International Standard) International Standard
16/360	Influenza Virus Infectious NIB-96 41920 E7 Influenza
16/362	Influenza Virus Infectious NYMC X-291 42530 E8 Influenza
16/364	3rd International Standard for Prekallikrein Activator International Standard
16/366	Influenza Virus Infectious NYMC X-291A 42540 E8 Influenza
16/368	HSV-1 International Standard
16/374	Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard) International Standard
16/376	Plasmodium falciparum antigens (1st International Standard) International Standard
1-7	Fimbrae monoclonal antibody, clone 1-7 Non WHO Reference Material
17/100	Prostate Specific Antigen (human)(total: PSA-ACT + free PSA) International Standard
17/102	Prostate Specific Antigen (human) (Free), (2nd WHO International Standard) International Standard
17/106	Influenza Anti-A/Michigan/45/2015-like HA Serum Influenza
17/122	HSV-2 International Standard
17/124	Influenza Virus Infectious NYMC BX-63 42790 E10/E1 Influenza
17/126	Influenza Virus Infectious NYMC BX-63A 42780 E10/E1 Influenza
17/132	Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637) Influenza
17/136	Influenza Virus Infectious NIBRG-375 (H7N9) Influenza
17/142	Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1) Influenza
17/154	Influenza Antigen A/Michigan/45/2015 (NYMC X-275) Influenza
17/156	Influenza Virus Infectious CNIC-1701 42910 E9 Influenza
17/160	Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard) International Standard
17/162	Influenza Virus Infectious NYMC X-299 42920 E10 Influenza
17/164	Influenza Virus Infectious B/Maryland/15/2016 42800 E5 Influenza
17/182	Influenza Antigen A/Michigan/45/2015 (NYMC X-275) Influenza
17/184	Influenza Virus Infectious NIB-103 42610 E7 Influenza
17/190	Influenza Virus Infectious NYMC X-297 42940 E11 Influenza
17/194	Influenza Virus Infectious NIB-104 Influenza
17/204	1st International Standard for Darbepoetin International Standard
17/206	14th British Standard for Coagulation Factor VIII Concentrate, Human. Working Standard
17/210	Influenza Virus Infectious IVR-186 43310 E8 Influenza
17/212	Anti-human leukocyte antigen antibodies (negative serum) International Reference Reagent
17/232	Tumor Necrosis Factor alpha (human rDNA derived) Working standard single unit sales
17/236	Adalimumab (1st WHO International Standard) International Standard
17/238	Anti-human leukocyte antigen antibodies (strong positive plasma) International Reference Reagent
17/240	5% Immunoglobulin (Negative Control) Non WHO Reference Material
17/246	Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104) Influenza
17/252	Influenza Virus Infectious NYMC BX-69 43220 E13 Influenza
17/256	Influenza Virus Infectious NYMC BX-69A Influenza
17/258	Influenza Virus Infectious B/Alabama/2/2017 Influenza
17/264	Influenza Virus Infectious A/Michigan/45/2015 43470 E5 Influenza
18/100	Influenza Antigen B/Maryland/15/2016 Influenza
18/104	Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A) Influenza
18/108	Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum Influenza
18/110	Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186) Influenza
18/112	Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum Influenza
18/116	WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4) International Standard
18/118	1st International Standard for HCT 15 Cancer Genome International Standard
18/120	WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4) International Reference Reagent
18/130	1st International Standard for MOLT-4 Cancer Genome International Standard
18/132D	WHO Reference Reagent Lentiviral Vector Copy number by digital PCR 6.75 log 10 LV copies/ampoule International Reference Reagent
18/132Q	WHO Reference Reagent Lentiviral Vector Copy number by quantitative PCR 6.89 log 10 LV copies/ampoule International Reference Reagent
18/134	Influenza Virus Infectious NIBRG-301 (H5N1) Influenza
18/136	Influenza Virus Infectious NIBRG-14 (H5N1) Influenza
18/138	Influenza Virus Infectious NYMC X-307A Influenza
18/140	Influenza Virus Infectious NYMC X-307 Influenza
18/144	WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis International Standard
18/146	Pertussis antiserum (Human) panel Non WHO Reference Material
18/154	Bordetella pertussis, pertactin, PRN Non WHO Reference Material
18/156	WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4) International Reference Reagent
18/160	Influenza Virus Infectious NYMC X-311 Influenza
18/164	1st International Standard for ATDB102 Genome International Standard
18/166	Influenza Virus Infectious NIB-112 43990 E6 Influenza
18/168	Influenza Virus Infectious A/Switzerland/8060/2017 Influenza
18/170	Influenza anti-B/Colorado/06/2017-like HA serum Influenza
18/174	Influenza Virus Infectious A/Brisbane/1/2018 Influenza
18/180	2nd International Standard for Diphtheria Antitoxin Equine International Standard
18/184	Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard) International Standard
18/188	Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112) Influenza
18/190	Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311) Influenza
18/192	Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum Influenza
18/194	Influenza Virus Infectious NYMC X-275 (Influenza Reagent) Influenza
18/196	Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9) Influenza
18/204	1st International Standard Anti-citrullinated peptide antibodies (ACPA) International Standard
18/206	West Nile Virus - International Standard International Standard
18/208	WHO Reference Reagent for West Nile Virus lineage 2 RNA for NAT-based assays International Reference Reagent
18/210	Bevacizumab (1st WHO International Standard) International Standard
18/220	Anti-HPA 15b minimum potency reagent (WHO Reference Reagent) International Reference Reagent
18/226	Influenza Virus Infectious IVR-190 44250 E12 Influenza
18/230	Influenza Virus Infectious B/Colorado/06/2017 43460 E7 Influenza
18/234	Influenza Virus Infectious NIB116-B 44230 E5 Influenza
18/238	Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1) Influenza
18/240	Influenza Virus Infectious NYMC X-327 44280 E17 Influenza
18/242	Influenza Virus Infectious A/Kansas/14/2017 43880 E8 Influenza
18/244	Human Chorionic Gonadotropin (hCG) (6th International Standard) International Standard
18/248	Von Willebrand Factor Concentrate (WHO 3rd International Standard) International Standard
19/102	Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701) Influenza
19/104	Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2) Influenza
19/106	Influenza Virus Infectious IVR-195 44300 E9 Influenza
19/108	Trastuzumab (1st WHO international Standard) International Standard
19/112	Influenza Virus Infectious NIB-110 Influenza
19/114	Anti-Human Neutrophil Antibody 3a WHO Reference Reagent International Reference Reagent
19/116	1st WHO Plasmodium Vivax Antigen (LDH) International Standard
19/118	Ferritin (Human, Recombinant) International Standard
19/120	Influenza Virus Infectious X-327 A 44310 E18 Influenza
19/146	Influenza Virus Infectious CNIC-1903 Influenza
19/148	Influenza Virus Infectious CNIC-1902 44320 E10 Influenza
19/152	Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum Influenza
19/154	Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2) Influenza
19/156	Panel of recombinant antibody controls for Cytokine Release Assays Working standard single unit sales
19/160	Influenza Virus Infectious A/California/7/09 44430 E6 Influenza
19/164	VZV Nucleic acid amplification techniques (1st WHO International Standard) International Standard
19/166	Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard) International Standard
19/172	Influenza Virus Infectious BVR-11 Influenza
19/174	Influenza Virus Infectious IVR-197 (H3N2) 44850 E14 Influenza
19/176	Influenza Virus Infectious B/Victoria/705/2018 Influenza
19/178	1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human) International Standard
19/180	Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody Non WHO Reference Material
19/188	3rd International Standard Thrombin International Standard
19/192	Influenza Virus Infectious IVR-202 (H3N2) 44880 E10 Influenza
19/194	Influenza Virus Infectious B/Brisbane/35/2018 Influenza
19/198	1st WHO Reference Reagent for anti-malaria (Plasmodium Vivax) human plasma International Reference Reagent
19/204	Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived) Influenza
19/206	Influenza Virus Infectious X-181 45030 E8 Influenza
19/208	Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage) Influenza
19/210	Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived) Influenza
19/212	Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2) Influenza
19/216	Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716) Influenza
19/224	Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11 International Standard
19/226	Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58 International Standard
19/228	Influenza Virus Infectious A/South Australia/34/2019 Influenza
19/230	Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4 Influenza
19/238	Influenza Antigen B/Washington/02/2019 (B Victoria Lineage) Influenza
19/240	British Working Standard for Anti-HCV European Certification
19/244	Third WHO International Standard for Anti-Rabies Immunoglobulin International Standard
19/246	1st International Standard for human vascular endothelial growth factor-165 (VEGF165) International Standard
19/248	Working Standard for Anti-Rabies Immunoglobulin Non WHO Reference Material
19/256	Influenza Virus Infectious BX-85C 45230 E13 Influenza
19/258	Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1 Influenza
19/260	Anti-thyroid peroxidase antibodies (1st WHO International Standard) International Standard
19/276	Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5 Influenza
19/290	First WHO International Standard for anti-human papillomavirus type 33 serum International Standard
19/296	First WHO International Standard for anti-human papillomavirus type 52 serum International Standard
19/298	First WHO International Standard for anti-human papillomavirus type 6 serum International Standard
19/300	First WHO International Standard for anti-human papillomavirus type 58 serum International Standard
19/306	Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1) Influenza
19/308	Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived) Influenza
19/312	Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1) Influenza
19/314	Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728) Influenza
19/316	Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734) Influenza
19/318	Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742) Influenza
19/320	Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736) Influenza
19/322	Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum Influenza
20/102	Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1 Influenza
20/106	Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1 Influenza
20/108	Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2) Influenza
20/110	SARS-CoV-2 (NAT) Clinical Virology Network
20/112	IVIG + Anti-D (13/148) x2 Negative Control IVIG (12/300) x2 Non WHO Reference Material
20/132	Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2) Influenza
20/134	Influenza Virus Infectious BX-57 45430 E4/E10/E1 Influenza
20/138	Working Reagent for SARS-CoV-2 RNA Non WHO Reference Material
20/146	First WHO International Standard for SARS-CoV-2 RNA International Standard
20/152	First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays International Standard
20/162	NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant (20/162) Quality Control Reagent
20/164	Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1 Influenza
20/170	NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT) Clinical Virology Network
20/172	1st International Standard for anti-EV68 Serum International Standard
20/174	First WHO International Standard for anti-human papillomavirus type 11 serum International Standard
20/176	First WHO International Standard for anti-human papillomavirus type 31 serum International Standard
20/178	First WHO International Standard for anti-human papillomavirus type 45 serum International Standard
20/180	Influenza A (H1N1) Panel Non WHO Reference Material
20/182	Influenza A (H3N2) Panel Non WHO Reference Material
20/184	Influenza B Panel Non WHO Reference Material
20/186	RSV A Panel Non WHO Reference Material
20/188	RSV B Panel Non WHO Reference Material
20/190	SARS-CoV-2 Panel Non WHO Reference Material
20/202	Anti-Lassa Virus Antibodies (1st International Standard) International Standard
20/214	Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1 Influenza
20/218	Follicle Stimulating Hormone (3rd International Standard) International Standard
20/220	Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1 Influenza
20/234	Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754) Influenza
20/236	Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720 Influenza
20/238	Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730 Influenza
20/250	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 1 International Standard
20/252	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 2 International Standard
20/254	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 3 International Standard
20/256	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Types 1, 2 and 3 International Standard
20/264	Influenza Virus Infectious X-341 + 1P (H3N2) Influenza
20/292	2nd International Standard for Factor XIII Plasma, Human International Standard
20/294	Influenza Virus Infectious X-347 (H3N2) Influenza
20/296	Influenza Virus Infectious X-347A (H3N2) Influenza
20/302	WHO International Reference Reagent for GUT Microbiome analysis by NGS (Gut-Mix RR) International Reference Reagent
20/304	WHO Reference Reagent for GUT Microbiome analysis by NGS (DNA-Gut-HiLo) International Reference Reagent
20/310	Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2) Influenza
20/314	2nd WHO International Standard For Meningococcal Capsular Group C Polysaccharide International Standard
20/318	Influenza Virus Infectious IVR-221 (H3N2) Influenza
20/322	Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2) Influenza
21/100	Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2) Influenza
21/110	Working Reagent for Lassa virus RNA Non WHO Reference Material
21/112	First WHO International Standard for Lassa virus RNA International Standard
21/116	Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2) Influenza
21/118	Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum Influenza
21/120	Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum Influenza
21/122	Influenza Virus Infectious X-357A (H3N2) Influenza
21/124	Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage) Influenza
21/130	Influenza Virus Infectious SAN-004A (H3N2) Influenza
21/136	Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage) Influenza
21/142	9th International Standard Factor VIII Concentrate, Human International Standard
21/148	Influenza Virus Infectious X-359 (H3N2) Influenza
21/150	Influenza Virus Infectious X-359A (H3N2) Influenza
21/156	Influenza Virus Infectious BX-93A (B-Victoria Lineage) Influenza
21/158	Influenza Virus Infectious BX-93B (B-Victoria Lineage) Influenza
21/160	Influenza Virus Infectious X-353 (H3N2) Influenza
21/164	Influenza Virus Infectious X-355B (H3N2) Influenza
21/166	Influenza Virus Infectious X-355A-CL (H3N2) Influenza
21/170	1st International Standard 2022 for the in vitro bioactivities of Cetuximab International Standard
21/180	Meningococcal Capsular Group W polysaccharide Non WHO Reference Material
21/186	Influenza Virus Infectious A/Tasmania/503/2020 (H3N2) Influenza
21/190	Influenza Virus Infectious X-361A (H3N2) Influenza
21/192	Influenza Virus Infectious BX-97A (B-Victoria Lineage) Influenza
21/194	Influenza Virus Infectious A/Hong Kong/2671/2019 Influenza
21/196	Influenza Virus Infectious IVR-224 (H3N2) Influenza
21/204	Influenza Virus Infectious IVR-227 (H3N2) Influenza
21/212	Influenza Virus Infectious A/Darwin/6/2021 (H3N2) Influenza
21/214	Influenza Virus Infectious A/Darwin/9/2021 (H3N2) Influenza
21/216	Influenza Virus Infectious BVR-25 (B-Victoria Lineage) Influenza
21/224	Influenza Virus Infectious B/Austria/1359417/2021 (B/Victoria Lineage) Influenza
21/226	Influenza Virus Infectious NIB-127 (H3N2) Influenza
21/228	Influenza Virus Infectious NIB-126 (H3N2) Influenza
21/230	1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test International Standard
21/238	Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1) Influenza
21/240	Influenza Virus Infectious CNIC-1909 (H1N1) Influenza
21/242	Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage) Influenza
21/244	Influenza Virus Infectious B/Michigan/1/2021 (B/Victoria Lineage) Influenza
21/246	Influenza Virus Infectious IVR-228 (H3N2) Influenza
21/248	Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580 Influenza
21/266	1st International Standard 2022 Anti-β2GPI IgG 200 IU/Vial International Standard
21/268	Anti-pneumococcal serotype 1 monoclonal antibody (clone13-110A Non WHO Reference Material
21/270	Anti-pneumococcal serotype 3 monoclonal antibody (clone 15-103FC11 IH5) Non WHO Reference Material
21/272	Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366LC1 IE11) Non WHO Reference Material
21/274	Anti-pneumococcal serotype 6A / 6C monoclonal antibody (clone 14-107 JG10 IA1/IB1 IIG10) Non WHO Reference Material
21/276	Anti-pneumococcal serotype 7F monoclonal antibody (clone 15-102HG6 ID8) Non WHO Reference Material
21/278	Anti-pneumococcal serotype 8 monoclonal antibody (clone 7D3) Non WHO Reference Material
21/280	Anti-pneumococcal serotype 9N monoclonal antibody (clone 18-125BG4 ID4) Non WHO Reference Material
21/282	Anti-pneumococcal serotype 9V monoclonal antibody (clone 15-112EG9 IE2) Non WHO Reference Material
21/284	Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117IA3 IIB6) Non WHO Reference Material
21/286	Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C1) Non WHO Reference Material
21/288	Anti-pneumococcal serotype 14 monoclonal antibody (clone 13-111A) Non WHO Reference Material
21/290	Anti-pneumococcal serotype 18C monoclonal antibody (clone 15-104AG5 IIH4) Non WHO Reference Material
21/292	Anti-pneumococcal serotype 19A monoclonal antibody (clone 14-105IH8 IE12) Non WHO Reference Material
21/294	Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 CG1 IC3) Non WHO Reference Material
21/298	Influenza Virus Infectious A/Michigan/173/2020 (H3N2) Influenza
21/308	2nd International Standard for Interleukin-6 International Standard
21/314	Influenza Antigen A/Darwin/6/2021 (IVR-227) (H3N2) Influenza
21/316	Influenza Antigen B/Austria/1359417/2021 (BVR-26) (B Victoria Lineage) Influenza
21/318	Influenza Antigen A/Darwin/9/2021 (IVR-228) (H3N2) Influenza
21/320	Influenza Antigen A/Darwin/9/2021 (SAN-010) (H3N2) Influenza
21/322	Influenza Anti-B Neuraminidase Serum (B/Phuket/3073/2013) Influenza
21/330	Influenza Antigen B/Michigan/01/2021 (B/Victoria Lineage) Influenza
21/332	1st International Reference Panel for anti-Lassa fever virus antibodies International Standard
21/336	Influenza Virus Infectious B/Washington/02/2019 (B-Victoria lineage) Influenza
21/338	1st International Standard 2022 Antibodies to SARS-CoV-2 variants of concern International Standard
21/340	Second WHO International Standard for anti-SARS-CoV-2 immunoglobulin. International Standard
21/344	Follicle Stimulating Hormone and Luteinising hormone, human, urinary (6th WHO International Standard) International Standard
21/346	Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) Influenza
21/348	Influenza Virus Infectious B/Utah/9/2014 (B-Yamagata lineage) Influenza
21/350	Influenza Virus Infectious BX-59A (B-Yamagata lineage) Influenza
21/352	Influenza Virus Infectious B/Brisbane/9/2014 (B-Yamagata) Influenza
21/366	Influenza Virus Infectious SAN-011 (H1N1) Influenza
21/368	SARS-Cov-2 Antigen 1st WHO International Standard International Standard
21/378	Anti-human leukocyte antigen antibodies (weak positive plasma) International Reference Reagent
21/380	Influenza Virus Infectious IVR-208 (H3N2) Influenza
21/382	Influenza Virus Infectious X-367A (H3N2) Influenza
21/384	Influenza Virus Infectious X-369A (H3N2) Influenza
21/388	Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage) Influenza
22/100	Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1) Influenza
22/104_BA	1st International Standard 2023 Rift Valley fever virus antibodies for binding assays (Human Plasma) International Standard
22/104_NT	1st International Standard 2023 Rift Valley fever virus antibodies for neutralisation assays (Human Plasma) International Standard
22/108	Reference Panel for Lassa virus RNA Non WHO Reference Material
22/118	Influenza Virus Infectious NIB-129 (H3N2) Influenza
22/120	Hepatitis B Virus DNA for NAT (5th WHO International Standard) International Standard
22/134	Influenza Virus Infectious BX-107A (B-Victoria Lineage) Influenza
22/136	Influenza Virus Infectious A/North Carolina/01/2021 (H1N1) X-375 Influenza
22/138	Influenza Virus Infectious A/Indiana/02/2020 (H1N1) Influenza
22/140	Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012 Influenza
22/142	Influenza Virus Infectious A/Sydney/5/2021 (H1N1) SAN-013 Influenza
22/144	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014 Influenza
22/146	Influenza Virus Infectious A/Brisbane/02/2018 (H1N1) Influenza
22/148	Meningococcal Capsular Group Y Polysaccharide Non WHO Reference Material
22/154	Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage) Influenza
22/156	Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X-373A Influenza
22/158	Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377 Influenza
22/172	Influenza Virus Infectious A/Lyon/820/2021 (H1N1) NIB-132 Influenza
22/174	Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) NYMC X-379 Influenza
22/178	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130 Influenza
22/180	Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206 Influenza
22/200	Influenza Virus Infectious A/Sydney/5/2021 (H1N1) Influenza
22/204	Influenza Virus Infectious B/Austria/1359417/2021 (B-Victoria lineage) BVR-26 Influenza
22/210	WHO International Reference Reagent for Gut Microbiome DNA Extraction (whole cell) International Reference Reagent
22/214	Influenza Virus Infectious CBER-48A (A/Sydney/5/2021) (H1N1) Influenza
22/216	Alpha-Fetoprotein, Human (2nd WHO International Standard) International Standard
22/218	Working Reagent for anti-monkeypox virus antibodies Non WHO Reference Material
22/220	Influenza Antigen A/Sydney/5/2021 (SAN-013) (H1N1) Influenza
22/222	Influenza Antigen A/Sydney/175/2022 (IVR-235) (H1N1) Influenza
22/224	Influenza anti-A/Sydney/5/2021-like (H1N1) HA serum Influenza
22/226	Influenza Anti-A/Darwin/9/2021-like (H3N2) HA Serum Influenza
22/228	Influenza Anti-B/Austria/1359417/2021-like (B Victoria lineage) HA Serum Influenza
22/234	Influenza Virus Infectious IVR-235 (A/Sydney/175/2022 (H1N1) Influenza
22/236	Anti-pneumococcal serotype 2 monoclonal antibody (clone 2D1) Non WHO Reference Material
22/238	Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2H7) Non WHO Reference Material
22/240	Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102GA3 ID10 1B10) Non WHO Reference Material
22/242	Anti-pneumococcal serotype 11A monoclonal antibody (clone 8G12) Non WHO Reference Material
22/244	Anti-pneumococcal serotype 15B monoclonal antibody (clone 3D3) Non WHO Reference Material
22/246	Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120DG2 IF2) Non WHO Reference Material
22/248	Anti-pneumococcal serotype 20 monoclonal antibody (clone 18-121 DF9 IIG8 1B6) Non WHO Reference Material
22/250	Anti-pneumococcal serotype 33F monoclonal antibody (clone 3B2) Non WHO Reference Material
22/254	Anti-pneumococcal serotype 6C monoclonal antibody (clone 1B2) Non WHO Reference Material
22/256	Anti-pneumococcal serotype 15A/B monoclonal antibody (clone 3A4) Non WHO Reference Material
22/258	Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121HC4 IA4 IE6) Non WHO Reference Material
22/260	Anti-pneumococcal serotype 19F monoclonal antibody (clone 8E9- 1B12) Non WHO Reference Material
22/262	Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA6 IG2) Non WHO Reference Material
22/264	Anti-pneumococcal serotype 24F monoclonal antibody (clone 1A6) Non WHO Reference Material
22/266	Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F6) Non WHO Reference Material
22/268	Influenza Virus Infectious SAN-015 (A/Lyon/820/2021) (H1N1) Influenza
22/270	1st International Reference Panel for antibodies to SARS-CoV-2 variants of concern International Standard
22/272	1st International Reference Panel for Infliximab anti-drug antibodies International Standard
22/274	Influenza Virus Infectious IVR-215 (A/Victoria/2570/2019) (H1N1) Influenza
22/276	Anti-pneumococcal serotype 2 monoclonal antibody (clone 1G7) Non WHO Reference Material
22/278	Anti-pneumococcal serotype 15B monoclonal antibody (clone 2F4) Non WHO Reference Material
22/280	Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA5 IE2 IE2) Non WHO Reference Material
22/282	Anti-pneumococcal serotype 24F monoclonal antibody (clone 2F2) Non WHO Reference Material
22/284	Anti-pneumococcal serotype CPS monoclonal antibody (clone 14-108BA5 IE10) Non WHO Reference Material
22/286	Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2G6) Non WHO Reference Material
22/288	Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366KG3 IA11) Non WHO Reference Material
22/290	Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102CC2 ID9) Non WHO Reference Material
22/292	Anti-pneumococcal serotype 8 monoclonal antibody (clone 6G1) Non WHO Reference Material
22/294	Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117DE8 IIE9) Non WHO Reference Material
22/296	Anti-pneumococcal serotype 11A monoclonal antibody (clone 2E2) Non WHO Reference Material
22/298	Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C8) Non WHO Reference Material
22/300	Anti-pneumococcal serotype 15A-B monoclonal antibody (clone 1B4) Non WHO Reference Material
22/302	Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121EC11 IIF10 VE2) Non WHO Reference Material
22/304	Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120AE4 IE3 IG2) Non WHO Reference Material
22/306	Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 JB11 IB11) Non WHO Reference Material
22/308	Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F9) Non WHO Reference Material
22/312	Influenza Virus Infectious A/Norway/31694/2022 (H1N1) Influenza
22/316	Influenza Virus Infectious A/Victoria/4897/2022 (H1N1) Influenza
22/318	Influenza Virus Infectious IVR-238 (A/Victoria/4897/2022 (H1N1) Influenza
22/320	Influenza Antigen A/Victoria/4897/2022 (IVR-238) (H1N1) Influenza
23/100	Influenza anti-A/Victoria/4897/2022-like (H1N1) HA Serum Influenza
23/106	Methylated Human Serum Albumin (mHSA) Non WHO Reference Material
23/112	Influenza Virus Infectious NIB-133 (A/Norway/31694/2022) (H1N1) Influenza
23/114	Influenza Virus Infectious SAN-010 (A/Darwin/09/2021) (H3N2) Influenza
23/116	Influenza Virus Infectious SAN-018 (A/Maryland/02/2021) (H3N2) Influenza
23/118	Influenza Virus Infectious SAN-019 (A/Alaska/01/2021) (H3N2) Influenza
23/120	Influenza Virus Infectious A/Wisconsin/67/2022 (H1N1) Influenza
23/122	Influenza Virus Infectious A/West Virginia/30/2022 (H1N1) Influenza
23/126	Influenza Virus Infectious NIB-134 (A/Catalonia/NSVH161512065/2022 (H1N1) Influenza
23/132	Influenza Virus Infectious NYMC BX-117 (B/Zhejiang-Nanhu/1854/2021) (B-Victoria lineage) Influenza
23/134	Influenza Virus Infectious NYMC X-387 (A/Maryland/02/2021) (H3N2) Influenza
23/136	Influenza Virus Infectious NYMC X-391 (A/Guizhou-Liuhite/326/2021) (H3N2) Influenza
23/138	Influenza Virus Infectious NYMC X-391A (A/Guizhou-Liuzhite/326/2021) (H3N2) Influenza
23/142	Anti-Meningococcal Human Reference Serum Group B Non WHO Reference Material
23/150	Bordetella Pertussis 18323 coating antigen Non WHO Reference Material
23/152	Influenza Virus Infectious NYMC X-393 (A/West Virginia/30/2022) (H1N1) Influenza
23/154	Influenza Virus Infectious NYMC X-393A (A/West Virginia/30/2022) (H1N1) Influenza
23/156	Influenza Virus Infectious NYMC BX-115 (B/Zhejiang-Xiacheng/11085/2021 (B/Victoria lineage) Influenza
23/158	Influenza Virus Infectious B/Phuket/3073/2013 (B/Yamagata lineage) Influenza
23/200	Influenza Virus Infectious A/California/122/2022 (H3N2) Influenza
23/202	Influenza Virus Infectious A/Brandenburg/15/2022 (H3N2) Influenza
23/204	Influenza Virus Infectious A/Thailand/8/2022 (H3N2) Influenza
23/206	Influenza Virus Infectious IVR-237 A/Thailand/8/2022 (H3N2) Influenza
23/214	Influenza Virus Infectious CNIC-2301 (A/Sichuan-Qingyang/SWL1148/2023) (H1N1) Influenza
23/216	Influenza Virus Infectious A/Brisbane/837/2022 (H3N2) Influenza
23/220	Influenza Antigen A/Thailand/8/2022 (IVR-237) (H3N2) Influenza
23/222	Influenza anti-A/Thailand/8/2022-like (H3N2) HA serum Influenza
23/226	Influenza Antigen A/California/122/2022 (SAN-022) (H3N2) Influenza
23/238	Influenza Virus Infectious IVR-246 A/Brisbane/837/2022 (H3N2) Influenza
23/252	Influenza Virus Infectious A/Victoria/4897/2022 (H1N1) Influenza
234	IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234) Non WHO Reference Material
2BADS	Anti-Brucella Abortus Serum, Bovine (International Standard) International Standard
2CPBETAAT	Clostridium Perfringens Beta Antitoxin (2nd International Standard) International Standard
2CPEPAT	Clostridium Perfringens Epsilon Antitoxin (2nd International Standard) International Standard
32-1	Filamentous Haemagglutinin monoclonal antibody, clone 32-1 Non WHO Reference Material
3-5	Pertactin Monoclonal antibody, Clone 3-5 Non WHO Reference Material
520	IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520) Non WHO Reference Material
59/015	Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine Non WHO Reference Material
59/016	Corticotrophin (ACTH), Porcine (3rd International Standard) International Standard
59/021	Botulinum Antitoxin Equine Type A Non WHO Reference Material
60/001	Botulinum Antitoxin Equine Type B Non WHO Reference Material
60/013	Tetanus Antitoxin, Equine, for Bioassay Non WHO Reference Material
62/014	Lysine Vasopressin, Porcine Non WHO Reference Material
629E1	Pertussis toxoid monoclonal antibody, clone 629E1 Non WHO Reference Material
63/005	Gas Gangrene Antitoxin (Cl. Histolyticum), Equine Non WHO Reference Material
64/003	Rheumatoid Arthritis serum Human Non WHO Reference Material
64/014	Gas Gangrene Antitoxin (Cl. Septicum), Equine Non WHO Reference Material
64/024	Gas Gangrene Antitoxin (Cl. Oedematiens), Equine Non WHO Reference Material
65/119	Renin, Porcine Non WHO Reference Material
65/122	Long-acting Thyroid Stimulator, Human Non WHO Reference Material
66/138	Gastrin II, Porcine Non WHO Reference Material
66/153	Diphtheria Antitoxin, Equine Non WHO Reference Material
66/233	Anti-Nuclear Factor Serum (Homogenous) Human Non WHO Reference Material
67/037	Immunoglobulin D (IgD) Serum, Human Non WHO Reference Material
67/099	Immunoglobulins G, A & M Serum Human Non WHO Reference Material
67/183	Primary Biliary Cirrhosis Serum, Human Non WHO Reference Material
68/340	Anti-Nucleolar Factor Plasma, Human Non WHO Reference Material
68/356	Renin, Human (International Standard) International Standard
69/065	Autoimmune Antibody to Human Spermatazoa Non WHO Reference Material
69/194	Glucagon, Porcine (First International Standard) International Standard
69K/16	Pertactin monoclonal antibody, clone 69K/16 Non WHO Reference Material
70/302	Angiotensin II (25µg) Non WHO Reference Material
71/281	Anti-Malaria Plasma P Vivax Non WHO Reference Material
71/326	Anti-Malaria Plasma Vivax Ng2 Non WHO Reference Material
72/092	Anti-malaria Plasma: Plasmodium falciparum (Ghana) Non WHO Reference Material
72/096	Anti-Malaria Serum (P.Malariae) Non WHO Reference Material
72/341	Anti-Malaria Plasma P Falciparum Non WHO Reference Material
72/345	Anti-Malaria Plasma P Falciparum Non WHO Reference Material
72/348	Anti-Malaria Plasma P Vivax Non WHO Reference Material
73/517	Anti-D (Rho) Antibodies, Human European Certification
73/545	Placental Lactogen, Human (International Reference Preparation) International Standard
73/554	Cholera Vaccine (Inaba) Non WHO Reference Material
73/556	Cholera Vaccine (Ogawa) Non WHO Reference Material
73/601	Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation) International Standard
74/520	Serum Proteins (Other than Immunoglobulins) Human Non WHO Reference Material
74/581	Ancrod (1st International Reference Preparation) International Standard
75/506	Cocksfoot Pollen Extract Non WHO Reference Material
75/533	Chorionic Gonadotrophin, Human, for Radioiodination Non WHO Reference Material
75/535	Chorionic Gonadotrophin beta, Human, for Radioiodination Non WHO Reference Material
75/551	Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation) International Reference Preparation
75/569	Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation) International Reference Preparation
75/595	Blood Coagulation Factor Xa, Bovine Non WHO Reference Material
76/508	Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination Non WHO Reference Material
76/515	Mannan (Candida Albicans) Purified Non WHO Reference Material
76/522	Opacity 5IRP WHO International Standard International Standard
76/525	Anti-Birch Pollen Serum, Human Non WHO Reference Material
76/547	Influenza anti A/Victoria/3/75 Serum(goat) Influenza
76/575	Oxytocin(4th International Standard) International Standard
77/503	Anti-Cocksfoot Serum, Human Non WHO Reference Material
77/512	Lysine Vasopressin(1st International Standard) International Standard
77/531	Influenza anti A/New Jersey/8/76(H1N1) Serum Influenza
77/568	Influenza anti B/Hong Kong/8/73 Serum Influenza
77/584	Anti-D Pteronyssinus Serum, Human Non WHO Reference Material
77/600	Mannan (Candida Albicans) Purified Non WHO Reference Material
77/616	Twelve Grass Pollen Extract Non WHO Reference Material
77/643	Secretin Non WHO Reference Material
77/662	Acarus Siro Extract Non WHO Reference Material
77/664	Glycyphagus destructor Extract Non WHO Reference Material
78/517	Tyrophagus Putrescentiae Extract Non WHO Reference Material
78/543	Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard) International Standard
78/545	Anti-Aspergillus fumigatus Serum, Human Non WHO Reference Material
78/554	Luteinizing Hormone, Pituitary, alpha subunit (International Standard) International Standard
78/556	Luteinizing Hormone, Pituitary, beta subunit (International standard) International Standard
78/560	Influenza Antigen A/Texas/1/77 Influenza
78/569	Influenza anti A/Texas/1/77 Serum Influenza
78/575	Aspergillus Fumigatus Extract Non WHO Reference Material
78/582	Tyrophagus Longior Extract Non WHO Reference Material
78/628	Bee Venom Non WHO Reference Material
79/500	Parathyroid Hormone, HumanRef. Preparation) International Reference Preparation
79/516	Influenza anti A/Brazil/11/78 Serum (goat) Influenza
79/552	Influenza Antigen A/USSR/92/77 Influenza
79/558	Influenza Antigen A/USSR/92/77 Influenza
79/560	Influenza Antigen A/Brazil/11/78 Influenza
79/568	Influenza Antigen B/Hong Kong/8/73 Influenza
79/572	Prekallikrein Activator (PKA), Human Non WHO Reference Material
80/505	Growth Hormone, Human, Pituitary. WHO International Standard International Standard
80/517	Influenza Antigen A/Bangkok/1/79 Influenza
80/519	Influenza Antigen B/Singapore/222/79 Influenza
80/523	Influenza anti B/Singapore/222/79 Serum Influenza
80/525	Influenza anti A/Bangkok/1/79 Serum Influenza
80/590	Tetracosactide. International Ref. Preparation International Reference Preparation
81/535	Luteinizing Hormone, Human, Pituitary (3rd International Standard) International Standard
81/615	Thyroid Stimulating Hormone, Human, Pituitary (4th WHO International Standard) International Standard
82/508	Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment Non WHO Reference Material
82/512	Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment Non WHO Reference Material
82/518	Dermatophagoides Pteronyssinus Extract. WHO International Standard International Standard
82/520	Timothy Pollen Extract. WHO International Standard International Standard
82/585	Anti Poliovirus serum types 1,2 and 3 (3rd International Standard) International Standard
82/587	Interferon Gamma (Human, Leukocyte derived) Non WHO Reference Material
82/632	Parathyroid Hormone, Bovine. WHO International Standard International Standard
82/652	Human Serum Vitamin B12, Pernicous anaemia Non WHO Reference Material
83/501	Beta Thromboglobulin, Purified Human. WHO International Standard International Standard
83/505	Platelet Factor 4 Human, Purified. WHO International Standard International Standard
83/511	Insulin, Bovine. WHO International Standard International Standard
83/514	Interferon alpha-1D, (Human rDNA derived) WHO International Standard International Standard
83/515	Insulin, Porcine. WHO International Standard International Standard
83/537	Influenza Antigen A/Philippines/2/82 Influenza
83/545	Influenza anti A/Philippine/2/82 Serum Influenza
83/550	Influenza Antigen A/Brazil/11/78 Influenza
83/573	Prolactin, Human (4th WHO International Standard.) International Standard
83/575	Follicle Stimulating Hormone, Pituitary. WHO International Standard International Standard
84/514	Proinsulin, Bovine. International Ref. Preparation International Reference Preparation
84/522	Birch Pollen Extract. WHO International Standard International Standard
84/528	Proinsulin, Porcine. International Ref. Reagent International Reference Reagent
84/538	Influenza Antigen A/Chile/1/83 Influenza
84/542	Influenza Antigen B/Norway/1/84 Influenza
84/581	Short Ragweed Pollen Extract. WHO International Standard International Standard
84/614	Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard International Standard
84/628	Anti-c Serum, Human European Certification
84/636	Influenza anti B/USSR/100/83 Serum Influenza
84/640	Influenza anti A/Chile/1/8 Serum Influenza
84/677	Influenza anti A/equine/Miami/63 (H3N8) Serum(goat) Influenza
84/685	Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard International Standard
85/506	C-Reactive Protein, Human. WHO International Standard International Standard
85/516	Influenza anti A/Equine/Kentucky/1/81 HA Serum Influenza
85/520	Influenza Antigen A/Equine/Kentucky/1/81 Influenza
85/522	Thyroid Stimulating Hormone beta subunit Non WHO Reference Material
85/551	Anti-Rye Grass Serum, Human Non WHO Reference Material
85/616	Haemoglobin F Lysate, Raised. WHO Reference Reagent International Reference Reagent
85/669	Atrial Natriuretic Factor, Human. WHO International Standard International Standard
86/500	Interleukin- 2 (Human, rDNA derived)(2nd International Standard) International Standard
86/536	Angiotensin I Human Type Synthetic Non WHO Reference Material
86/538	Angiotensin II (2.5µg) Non WHO Reference Material
86/552	Interleukin-1 Beta (Human, rDNA derived) Non WHO Reference Material
86/576	Influenza Antigen A/Mississippi/1/85 Influenza
86/590	Influenza anti A/Mississippi/1/85 Serum Influenza
86/592	Influenza anti B/Ann Arbor/1/86/HA Serum Influenza
86/630	Influenza Antigen B/Ann Arbor/ 1/86 Influenza
86/632	Interleukin-1 alpha (Human rDNA derived) WHO International Standard International Standard
86/678	Interleukin-1 alpha (Human, rDNA derived) Non WHO Reference Material
86/680	Interleukin-1 beta (Human, rDNA derived) WHO International Standard International Standard
86/690	Inhibin, Porcine WHO International Standard International Standard
87/510	Influenza Antigen A/Equine/Miami/63 Influenza
87/578	Influenza anti A/Leningrad/360/86 Serum Influenza
87/584	Influenza Antigen A/Leningrad/360/86 Influenza
87/586	Interferon Gamma (Human, rDNA derived) Non WHO Reference Material
87/640	Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
87/654	Anti-Ferritin Monoclonal Antibody (1) Non WHO Reference Material
87/662	Anti-Ferritin Monoclonal Antibody (2) Non WHO Reference Material
87/714	Influenza Antigen A/Sichuan/2/87 Influenza
87/774	Influenza Antigen B/Victoria/2/87 Influenza
88/522	Bordetella pertussis (Whole cell vaccine) 3BRP Non WHO Reference Material
88/532	Tumour Necrosis Factor alpha (Mouse, rDNA derived) Non WHO Reference Material
88/554	Influenza Antigen B/Beijing/1/87 Influenza
88/556	Calcitonin, Eel WHO International Standard International Standard
88/638	Thyroxine-binding globulin. WHO International Standard International Standard
88/646	Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard International Standard
88/654	Influenza Antigen A/England/427/88 Influenza
88/656	Interleukin-4 (Human, rDNA derived) WHO International Standard International Standard
88/672	Influenza anti A/Sichuan/2/87 Serum Influenza
88/678	Influenza anti B/Beijing/1/87 Serum Influenza
88/846	Influenza anti A/England/427/88 Serum Influenza
89/512	Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard International Standard
89/514	Transforming Growth Factor beta-1 (Human, rDNA derived) Non WHO Reference Material
89/516	Transforming Growth Factor beta-1 (Bovine) Non WHO Reference Material
89/518	Transforming Growth Factor beta-2 (Bovine) Non WHO Reference Material
89/520	Interleukin-8 (Human, rDNA derived) WHO International Standard International Standard
89/530	Anti-Bordetella pertussis serum (Human) Non WHO Reference Material
89/544	Renin, Human, rec DNA Non WHO Reference Material
89/568	Influenza Antigen A/OMS/5389/88 Influenza
89/594	Bordetella pertussis (W28) LPS 2ug Non WHO Reference Material
89/596	Bordetella pertussis anti-agglutinogen 1(rabbit) Non WHO Reference Material
89/598	Bordetella pertussis anti-agglutinogen 2 (rabbit) Non WHO Reference Material
89/600	Bordetella pertussis anti-agglutinogen 3 (rabbit) Non WHO Reference Material
89/620	Calcitonin, Human. WHO International Standard International Standard
89/666	Haemoglobin A2 Lysate, Raised. WHO Reference Reagent International Reference Reagent
89/670	Bordetella pertussis (W28) LPS25ug Non WHO Reference Material
8E1-1H1.2.1	Tetanus toxoid monoclonal antibody, clone 8E1-1H1.2.1 Non WHO Reference Material
90/500	Influenza Antigen A/Shanghai/16/89 Influenza
90/502	Influenza Antigen A/Guizhou/54/89 Influenza
90/504	Influenza anti A/Guangdong/39/89 Serum Influenza
90/520	Bordetella pertussis, filamentous haemagglutinin (FHA) Non WHO Reference Material
90/530	Interleukin-7 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
90/534	Mumps Vaccine (Live) WHO Reference Reagent International Reference Reagent
90/586	Interleukin-5 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
90/636	HIV-1 P24 Antigen WHO International Standard International Standard
90/690	Anti-Varicella-Zoster Antibody European Certification
90/696	Transforming Growth Factor beta-2, Human, rec DNA Non WHO Reference Material
90/712	Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard International Standard
90/784	Influenza Virus infectious NIB-26 (H3N2) Influenza
91/510	Interleukin-3 (Human, rDNA derived) WHO International Standard International Standard
91/530	Epidermal Growth Factor (Human, rDNA derived) WHO International Standard International Standard
91/550	Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
91/554	Insulin-like growth Factor 1 WHO International Standard International Standard
91/612	Influenza anti A/Taiwan/1/86 Serum Influenza
91/624	Recombinant Human Inhibin International Standard
91/626	Activin A, Human, Recombinant. WHO Reference Reagent International Reference Reagent
91/656	Interleukin-4 (Mouse, rDNA derived) Non WHO Reference Material
91/658	Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived) Non WHO Reference Material
91/662	Interleukin-3 (Mouse, rDNA derived) Non WHO Reference Material
91/670	Influenza Virus infectious NIB-27 (H1N1) Influenza
91/678	Interleukin-9 (Human,rDNA derived) WHO Reference Reagent International Reference Reagent
91/682	Stem Cell Factor (Human rDNA derived) WHO Reference Reagent International Reference Reagent
91/688	1st International Reference Reagent Rubella Vaccine (Live) International Standard
92/510	Follicle Stimulating Hormone, Human, recombinant. (WHO International Standard) International Standard
92/512	Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard International Standard
92/518	Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived) Non WHO Reference Material
92/520	Rantes (Human, rDNA derived) Non WHO Reference Material
92/530	Influenza Antigen A/Texas/36/91 Influenza
92/582	Influenza anti B/Yamagata/16/88 Serum Influenza
92/628	Influenza Antigen B/Yamagata/16/88 Influenza
92/632	Influenza anti A/Beijing/352/89 (H3N2) Serum Influenza
92/644	Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived) Non WHO Reference Material
92/648	Measles Vaccine (Live) 2nd International Reference Reagent International Standard
92/654	Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard International Standard
92/658	Papain preparation for use with Anti-D preparation 91/562 Working Standard
92/734	Influenza Virus infectious A/Beijing/32/92 (H3N2) Influenza
92/738	Influenza Virus infectious A/Shanghai/24/90 Influenza
92/788	Interleukin-11 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
92/794	Monocyte Chemoattractant Protein-1 (Human,rDNA derived) Non WHO Reference Material
93/500	Influenza Antigen A/Beijing/32/92 Influenza
93/516	Influenza Antigen A/Shanghai/24/90 Influenza
93/518	Influenza anti A/Beijing/32/92 (H3N2) Serum Influenza
93/522	Influenza anti A/Shanghai/24/90 (H3N2) Serum Influenza
93/556	Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
93/560	Insulin-like growth Factor Binding Protein-3 Non WHO Reference Material
93/562	Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
93/564	Oncostatin M (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
93/566	Interleukin-2 (Mouse, rDNA derived) Non WHO Reference Material
93/568	Influenza Virus infectious A/Beijing/359/89 (H3N2) Influenza
93/574	Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
93/668	Interleukin-1 beta (Mouse, rDNA derived) Non WHO Reference Material
93/672	Interleukin-1 alpha (Mouse, rDNA derived) Non WHO Reference Material
93/692	Influenza Virus infectious B/Panama/45/90 Influenza
93/722	Interleukin-10 (Human rDNA derived) WHO Reference Reagent International Reference Reagent
93/730	Interleukin-6 (Mouse, rDNA derived) Non WHO Reference Material
93/740	Interleukin-7 (Mouse, rDNA derived) Non WHO Reference Material
93/816	Influenza Virus infectious A/Harbin/15/92 (H3N2) Influenza
94/500	Influenza Antigen B/Panama/45/90 Influenza
94/504	Influenza anti A/Shanghai/9/93 Serum Influenza
94/516	Influenza Antigen A/Shangdong/9/93 Influenza
94/520	Influenza anti B/Panama/45/90 Serum Influenza
94/532	Pertussis Vaccine (Whole Cell) WHO International Standard International Standard
94/622	Interleukin-13 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
94/674	Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent International Reference Reagent
94/684	Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
94/718	Staphylokinase, rec (STAR) Non WHO Reference Material
94/728	Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard International Standard
94/730	Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard International Standard
94/754	Interferon Omega (Human, rDNA derived) WHO International Standard International Standard
94/762	Influenza Virus infectious RESVIR-8 (H3N2) Influenza
94/766	Influenza Virus infectious NIB-34 (H3N2) Influenza
94/784	Interferon alpha (Human, leukocyte derived)WHO International Standard International Standard
94/786	Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard International Standard
94/790	MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard International Standard
95/510	Influenza Antigen A/Texas/36/91 Influenza
95/516	Influenza Antigen A/Johannesburg/33/94 Influenza
95/522	Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard International Standard
95/524	Influenza anti A/Johannesburg/33/94 Serum Influenza
95/528	Folate, Whole Blood Haemolysate WHO International Standard International Standard
95/542	MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard International Standard
95/544	Interleukin-12 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
95/554	Interleukin-15 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
95/564	Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc) Non WHO Reference Material
95/568	Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard International Standard
95/572	Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard International Standard
95/574	Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard International Standard
95/580	Interferon alpha-2c (Human, rDNA derived) WHO International Standard International Standard
95/646	Parathyroid Hormone 1-84, human, recombinant (1st International Standard) International Standard
95/650	Interferon alpha-2a (Human, rDNA derived) WHO International Standard International Standard
95/656	Interferon alpha 2b (Human rDNA derived)(3rd International Standard) International Standard
95/668	Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc) Non WHO Reference Material
95/674	Anti-Meningococcal Serogroup A mAb Non WHO Reference Material
95/678	Anti-Meningococcal Serogroup C mAb Non WHO Reference Material
96/528	Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived) Non WHO Reference Material
96/532	FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
96/534	Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
96/538	Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent International Reference Reagent
96/556	Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard International Standard
96/564	Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent International Reference Reagent
96/572	MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent International Reference Reagent
96/578	MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent International Reference Reagent
96/602	Luteinizing Hormone, Human, recombinant WHO International Standard International Standard
96/784	Inhibin B, Human WHO Reference Reagent International Reference Reagent
96/836	Influenza Virus infectious RESVIR-9 (H3N2) Influenza
96/850	Influenza Virus infectious NIB-39 (H1N1) Influenza
97/518	Influenza Antigen A/Johannesburg/82/96 Influenza
97/538	Anti-Granulocyte Macrophage Colony Stimulating Factor Serum Non WHO Reference Material
97/550	Islet Cell Antibodies WHO Reference Reagent International Reference Reagent
97/558	Bordetella pertussis anti 69kD serum (sheep) Non WHO Reference Material
97/564	Bordetella pertussis anti FHA serum (sheep) Non WHO Reference Material
97/572	Bordetella pertussis PT anti serum (sheep) Non WHO Reference Material
97/574	Bordetella pertussis anti Fim3 serum (sheep) Non WHO Reference Material
97/584	Influenza Antigen A/Equine/Newmarket/2/93 Influenza
97/594	Leptin, Human, Recombinant WHO International Standard International Standard
97/596	Influenza Antigen A/Equine/Newmarket/1/93 Influenza
97/600	Interleukin-2 Soluble Receptor (human, rDNA derived) Non WHO Reference Material
97/610	Influenza anti A/equine/Newmarket/1/93 Serum Influenza
97/612	Influenza anti- A/Nanchang/933/95 (H3N2) HA serum Influenza
97/614	Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376) Influenza
97/626	Leptin, Mouse, Recombinant WHO International Standard International Standard
97/642	Bordetella pertussis anti serum (mouse) 1RR International Reference Reagent
97/646	Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard International Standard
97/648	Anti-Measles serum (3rd International Standard) International Standard
97/692	Influenza Virus infectious IVR-108 (H3N2) Influenza
97/714	Prolactin, Human, recombinant. WHO Reference Reagent International Reference Reagent
97/722	Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3) Influenza
97/748	Influenza Antigen B/Harbin/7/94 Influenza
97/756	MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent International Reference Reagent
97/758	MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard International Standard
97/760	Influenza Antigen A/Beijing/262/95 Influenza
98/524	MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard International Standard
98/540	Anti-D Working Standard
98/544	Influenza Virus infectious RESVIR-13 (H3N2) Influenza
98/572	Diphtheria and Tetanus Antitoxin, Guinea Pig Serum Non WHO Reference Material
98/574	Somatropin WHO International Standard International Standard
98/580	Prolactin Human, recombinant, glycosylated WHO Reference Reagent International Reference Reagent
98/582	Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent International Reference Reagent
98/586	Calcitonin, Salmon. WHO International Standard International Standard
98/596	MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent International Reference Reagent
98/600	Influenza Virus infectious NIB-40 (H5N3) Influenza
98/604	Influenza anti B/Harbin/7/94/HA Serum Influenza
98/610	Influenza Virus infectious ARIV-1 (H5N3) Influenza
98/666	Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep) Influenza
98/686	Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology) Non WHO Reference Material
98/708	Haemiglobincyanide WHO International Standard International Standard
98/714	Tissue Plasminogen Activator, Human, Recombinant WHO International Standard International Standard
98/718	Neurotrophin 3 Non WHO Reference Material
98/762	Influenza Virus infectious Resvir-14 (H3N2) Influenza
98/772	Influenza anti A/Beijing/262/95 Serum Influenza
98/774	Influenza Antigen B/Shangdong/7/97 Influenza
98/778	Influenza Virus infectious A/Sichuan/346/98 (H3N2) Influenza
99/506	Anti-PT S1 subunit Monoclonal Antibody (1B7) Non WHO Reference Material
99/508	Anti-PT S1 subunit Monoclonal Antibody (1D7) Non WHO Reference Material
99/510	Anti-PT S1 subunit Monoclonal Antibody (3F11) Non WHO Reference Material
99/512	Anti-PT S1 subunit Monoclonal Antibody (10D6) Non WHO Reference Material
99/514	Anti-PT S1 subunit Monoclonal Antibody (8G4) Non WHO Reference Material
99/516	Anti-PT S1 subunit Monoclonal Antibody (E1E) Non WHO Reference Material
99/518	Anti-PT S1 subunit Monoclonal Antibody (E2E) Non WHO Reference Material
99/520	Anti-PT S1 subunit Monoclonal Antibody (3F10) Non WHO Reference Material
99/522	Anti-PT S1 subunit Monoclonal Antibody (11D9) Non WHO Reference Material
99/524	Anti-PT S1 subunit Monoclonal Antibody (4D10) Non WHO Reference Material
99/526	Anti-PT S23 subunit Monoclonal Antibody (11E6) Non WHO Reference Material
99/528	Anti-PT S23 subunit Monoclonal Antibody (10C9) Non WHO Reference Material
99/530	Anti-PT S23 subunit Monoclonal Antibody (10B5) Non WHO Reference Material
99/532	Anti-PT S23 subunit Monoclonal Antibody (G9A) Non WHO Reference Material
99/534	Anti-PT S23 subunit Monoclonal Antibody (3F6) Non WHO Reference Material
99/536	Anti-PT S2 subunit Monoclonal Antibody (3A12) Non WHO Reference Material
99/538	Anti-PT S2 subunit Monoclonal Antibody (2H3) Non WHO Reference Material
99/540	Anti-PT S2 subunit Monoclonal Antibody (9G8) Non WHO Reference Material
99/542	Anti-PT S3 subunit Monoclonal Antibody (7E10) Non WHO Reference Material
99/544	Anti-PT S3 subunit Monoclonal Antibody (7G11) Non WHO Reference Material
99/546	Anti-PT S3 subunit Monoclonal Antibody (4G5) Non WHO Reference Material
99/548	Anti-PT S3 subunit Monoclonal Antibody (2E12) Non WHO Reference Material
99/550	Anti-PT S3 subunit Monoclonal Antibody (6F8) Non WHO Reference Material
99/552	Anti-PT S3 subunit Monoclonal Antibody (10B8) Non WHO Reference Material
99/554	Anti-PT S4 subunit Monoclonal Antibody (7F2) Non WHO Reference Material
99/556	Anti-PT S4 subunit Monoclonal Antibody (6B3) Non WHO Reference Material
99/558	Anti-PT S4 subunit Monoclonal Antibody (6G8) Non WHO Reference Material
99/560	Anti-PT S4 subunit Monoclonal Antibody (9F3) Non WHO Reference Material
99/562	Anti-PT S4 subunit Monoclonal Antibody (1H2) Non WHO Reference Material
99/564	Anti-PT S4 subunit Monoclonal Antibody (9C6) Non WHO Reference Material
99/566	Anti-PT S4 subunit Monoclonal Antibody (6D6) Non WHO Reference Material
99/568	Anti-PT S5 subunit Monoclonal Antibody (7E3) Non WHO Reference Material
99/570	Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6) Non WHO Reference Material
99/572	Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9) Non WHO Reference Material
99/574	Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10) Non WHO Reference Material
99/586	Influenza Antigen B/Yamanashi/166/98 Influenza
99/614	Influenza Antigen A/Sydney/5/97 Influenza
99/616	Yellow Fever Vaccine. WHO International Standard International Standard
99/624	Influenza Antigen A/Sydney/5/97 Influenza
99/642	Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent International Reference Reagent
99/650	Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent International Reference Reagent
99/666	Anti-HPA-5b (Minimum Potency) WHO Reference Reagent International Reference Reagent
99/674	HIV-2 (antibody) Monitor Sample European Certification
99/688	Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent International Reference Reagent
99/692	Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent International Reference Reagent
99/706	Anti-Meningococcal human reference serum CDC1992 Non WHO Reference Material
99/708	Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent International Reference Reagent
99/710	Anti-HIV 1 (1 in 5 BWS) European Certification
99/720	Chorionic Gonadotrophin, alpha subunit, Human (purified) International Standard
99/750	British Working Standard for Anti-HIV 1 European Certification
99/824	Influenza Virus infectious RESVIR 16 (H3N2) Influenza
99/828	Influenza Antigen B/Yamanashi/166/98 Influenza
99/836	Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard International Standard
BUSB	Botulinum Antitoxin Equine Type B. WHO International Standard International Standard
CDS	Anti-Canine Distemper Serum. WHO International Standard International Standard
CHAN	Cholera Antitoxin, Goat. WHO International Standard International Standard
CHS	Anti-Canine Hepatitis Serum International Standard
COT	Clostridium novyi (alpha) Toxoid. WHO Reference Reagent International Reference Reagent
CWBETATD	Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent International Reference Reagent
CWEPSILTD	Clostridium Welchii (Perfringens) (Epsilon) toxoid International Reference Reagent
DIM9	Diphtheria toxoid monoclonal antibody, clone Dim9 Non WHO Reference Material
DT05	Diphtheria toxoid monoclonal antibody, clone DT05 Non WHO Reference Material
DY	Anti-Dysentery (shiga) serum, Equine. WHO International Standard International Standard
FHADETOX/6	Filamentous Haemagglutinin monoclonal antibody, clone FHADETOX/6 Non WHO Reference Material
G10F8C3	Fimbrae monoclonal antibody, clone G10F8C3 Non WHO Reference Material
HBOHA	Lyophilised HBO-HA Antigen for ELISA, Lot 17 Non WHO Reference Material
JNIH-11	Bordetella pertussis anti FHA serum (mouse) Non WHO Reference Material
JNIH-12	Bordetella pertussis PT( LPF) anti serum, (mouse) Non WHO Reference Material
JNIH-3	Acellular Pertussis Vaccine - 1st IS. International Standard
JNIH-4	Bordetella pertussis filamentous haemagglutinin (FHA) Non WHO Reference Material
MEF/001	Primary Mouse Embryo Fibroblasts (p0) UK Stem Cell Bank
MGDS	Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent International Reference Reagent
NDS	Anti-Newcastle Disease Serum. WHO International Standard International Standard
NVIA	Newcastle Disease Vaccine (Inactivated) WHO International Standard International Standard
OE	Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard International Standard
PE	Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard International Standard
PPDBOV	Purified Protein Derivative (PPD) of Mycobacterium bovis Tuberculin (WHO 1st International Standard) International Standard
PPDT	Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard International Standard
PS21C2.2.1	Pertussis toxoid monoclonal antibody, clone PS21C2.2.1 Non WHO Reference Material
QCRCMVIGMQC1	QCRCMVIgMQC1 IgM Anti-CMV QC1 (16/B693) Quality Control Reagent
QCRCMVQC1	Anti CMV QC1 QCRCMVQC1 (18/B731) Quality Control Reagent
QCREBVIGMQC1	QCREBVIgMQC1 (18/B733) Quality Control Reagent
QCREBVVCAQC1	QCREBVVCAQC1 (16/B697) Quality Control Reagent
QCRFERRQC1	QCRFERRQC1 - Ferritin Quality Control Sample (21/B777) Quality Control Reagent
QCRHAVIGMQC2	QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 (13/B634) Quality Control Reagent
QCRHBCIGMQC1	QCRHBcIgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 (07/B498) Quality Control Reagent
QCRHBSGQC1	QCRHBsGQC1-HBsAg Quality Control Serum: Sample1 (17/B717) Quality Control Reagent
QCRHBSGQC2	QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 (22/B893) Quality Control Reagent
QCRHBSQC1	QCRHBsQC1 (20/B760) Quality Control Reagent
QCRHCVQC1	QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 (21/B889) Quality Control Reagent
QCRHEVIGMQC1	QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1 (17/B728) Quality Control Reagent
QCRHEVQC1	QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1 (17/B723) Quality Control Reagent
QCRHIV1P24QC2	QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 (20/B758) Quality Control Reagent
QCRHIV1QC1	QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 (11/B608) Quality Control Reagent
QCRHIV1QC2	QCRHIV1QC2 - Anti-HIV Quality Control Serum sample 2 (20/B762) Quality Control Reagent
QCRHIV1QC3	QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3 (13/B644) Quality Control Reagent
QCRHIV1QC5	QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5 (13/B640) Quality Control Reagent
QCRHIV2QC2	QCRHIV2QC2 - Anti HIV2: Quality Control Serum: Sample2 (22/B895) Quality Control Reagent
QCRHIV2QC3	QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 (14/B653) Quality Control Reagent
QCRHIV2QC4	QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4 (19/B747) Quality Control Reagent
QCRHSV1QC1	QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1 (21/B882) Quality Control Reagent
QCRHSV2QC1	QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1 (13/B642) Quality Control Reagent
QCRLYMEIGMQC1	QCRLYMEIgMQC1 IgM Anti-Lyme QC1 (18/B742) Quality Control Reagent
QCRLYMEQC1	QCRLYMEQC1 - Anti-Lyme QC1 (15/B658) Quality Control Reagent
QCRMEASQC1	QCRMEASQC1 Anti-Measles QC1 (15/B667) Quality Control Reagent
QCRMUMPSQC1	QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1 (15/B664) Quality Control Reagent
QCRNEGQC1	QCRNEGQC1 - Negative Quality Control Serum: Sample1 (18/B732) Quality Control Reagent
QCRPARVB19IGMQC1	QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1 (20/B774) Quality Control Reagent
QCRPARVB19QC1	QCRPARVB19QC1 Anti-Parvovirus B19QC1 (15/B678) Quality Control Reagent
QCRRUBIGMQC1	QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1 (12/B612) Quality Control Reagent
QCRRUBQC1	QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1 (14/B654) Quality Control Reagent
QCRRUCQC2	QCRRUBQC2 - Anti-Rubella QC2 (19/B754) Quality Control Reagent
QCRSYPHQC1	QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 (20/B767) Quality Control Reagent
QCRTHAVQC1	QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 (17/B725) Quality Control Reagent
QCRTHBCQC1	QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 (16/B704) Quality Control Reagent
QCRTHBCQC2	QCRTHBcQC2 -Total Anti-HBc Quality Control Serum Sample 2 (23/B902) Quality Control Reagent
QCRTOXOIGMQC1	QCRTOXOIgMQC1 IgM Anti-Toxoplasma QC1 (22/B891) Quality Control Reagent
QCRTOXOQC1	QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1 (17/B710) Quality Control Reagent
QCRVZVQC1	QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1 (14/B655) Quality Control Reagent
QF	Anti-Q Fever Serum, Bovine WHO International Standard International Standard
RBT/16	Thromboplastin, Rabbit, Plain 5th International Standard 2016. International Standard
RTF/16	Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016. International Standard
RUBI-1-94	Anti-rubella Immunoglobulin, Human WHO International Standard International Standard
SES	Swine Erysipelas Serum (anti-N) WHO Reference Reagent International Reference Reagent
SFS	Anti-Swine Fever Serum WHO International Standard International Standard
SMV	Smallpox Vaccine WHO International Standard International Standard
SPDS-S2	Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard International Standard
SPDS-V	Anti-Salmonella Pullorum Serum (Variant Form V) (WHO International Standard) International Standard
SPLS	Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent International Reference Reagent
SS-319/20	FITC CD4 Positive Control Cells Non WHO Reference Material
SSCLOT5	SSC Secondary Coagulation Standard Lot#5 Non WHO Reference Material
STA	Staphylococcus Alpha Antitoxin, Equine WHO International Standard International Standard
STT	Diphtheria (Schick) Test Toxin WHO International Standard International Standard
TILI	Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard International Standard
TISA	Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard International Standard
TT010	Tetanus toxoid monoclonal antibody, clone TT010 Non WHO Reference Material
TYVK	Typhoid Vaccine (acetone-inactivated) WHO International Standard International Standard
TYVL	Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard International Standard
VI	Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard International Standard
W1004	Anti-C complete blood typing serum,human WHO International Standard International Standard
W1005	Anti-E complete blood typing serum, human WHO International Standard International Standard
W1007	Anti-C Incomplete blood typing serum, human WHO International Standard International Standard
W1062	Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent International Reference Reagent
W1063	Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent International Reference Reagent
W1064	Anti-Nuclear factor serum,homogenous(66/233) Non WHO Reference Material
YF	Anti-Yellow Fever Serum, monkey WHO Reference Reagent International Reference Reagent